Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Prof. Dr. med. Jan Dürig

Telefax
duerig@t-online

Funktionen

  • ---, Zentrum für Innere Medizin

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Kriegsmann, Katharina; Ton, Gigi Nu Hoang Quy; Awwad, Mohamed H. S.; Benner, Axel; Bertsch, Uta; Besemer, Britta; Hänel, Mathias; Fenk, Roland; Munder, Markus; Dürig, Jan; Blau, Igor W.; Huhn, Stefanie; Hose, Dirk; Jauch, Anna; Mann, Christoph; Weinhold, Niels; Scheid, Christof; Schroers, Roland; von Metzler, Ivana; Schieferdecker, Aneta; Thomalla, Jörg; Reimer, Peter; Mahlberg, Rolf; Graeven, Ullrich; Kremers, Stephan; Martens, Uwe M.; Kunz, Christian; Hensel, Manfred; Seidel-Glätzer, Andrea; Weisel, Katja C.; Salwender, Hans J.; Müller-Tidow, Carsten; Raab, Marc S.; Goldschmidt, Hartmut; Mai, Elias K.; Hundemer, Michael
    CD8⁺ CD28⁻ regulatory T cells after induction therapy predict progression-free survival in myeloma patients : Results from the GMMG-HD6 multicenter phase III study
    In: Leukemia , Jg. 38 2024, Nr. 7, S. 1621 – 1625
    DOI (Open Access)
  • Mai, Elias K; Goldschmid, Hartmut; Miah, Kaya; Bertsch, Uta; Besemer, Britta; Hänel, Mathias; Krzykalla, Julia; Fenk, Roland; Schlenzka, Jana; Munder, Markus; Dürig, Jan; Blau, Igor W; Huhn, Stefanie; Hose, Dirk; Jauch, Anna; Kunz, Christina; Mann, Christoph; Weinhold, Niels; Scheid, Christof; Schroers, Roland; von Metzler, Ivana; Schieferdecker, Aneta; Thomalla, Jörg; Reimer, Peter; Mahlberg, Rolf; Graeven, Ullrich; Kremers, Stephan; Martens, Uwe M; Kunz, Christian; Hensel, Manfred; Benner, Axel; Seidel-Glätzer, Andrea; Weisel, Katja C; Raab, Marc S; Salwender, Hans J; Adrian, Nicole; Bernhard, Helga; Böck, Hans-Peter; Bolling, Claus; Dingeldein, Gerrit; Emde, Till-Oliver; Ferstl, Barbara; Fietz, Thomas; Fronhoffs, Stefan; Fuhrmann, Stephan; Fuxius, Stefan; Geer, Thomas; Görner, Martin; Guenther, Barbara; Hartmann, Frank; Heilmeier, Bernhard; Heinsch, Michael; Hoffmann, Martin; Holderried, Tobias A.W.; Klein, Stefan; Klump, Martin; Knauf, Wolfgang; La Rosée, Paul; Lange, Elisabeth; Lindemann, Walter; Lopez, Roderico; Mayer, Frank; Nückel, Holger; Papesch, Eva; Procaccianti, Maria; Reichart, Alexander; Rummel, Mathias; Scheuer, Lars; Schmitt, Hans-Roland; Staib, Peter; Steiniger, Heike; Tischler, Hans-Joachim; Ulshöfer, Thomas; Verbeek, Walter; Wacker, Alexander; Zirpel, Iris; Goldschmidt, Hartmut
    Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial
    In: The Lancet Haematology , Jg. 11 2024, Nr. 2, S. e101 – e113
    DOI (Open Access)
  • Fürstenau, Moritz; Kater, Arnon P; Robrecht, Sandra; von Tresckow, Julia; Zhang, Can; Gregor, Michael; Thornton, Patrick; Staber, Philipp B; Tadmor, Tamar; Lindström, Vesa; Juliusson, Gunnar; Janssens, Ann; Levin, Mark-David; da Cunha-Bang, Caspar; Schneider, Christof; Goldschmidt, Neta; Vandenberghe, Elisabeth; Rossi, Davide; Benz, Rudolf; Nösslinger, Thomas; Heintel, Daniel; Poulsen, Christian B; Christiansen, Ilse; Frederiksen, Henrik; Enggaard, Lisbeth; Posthuma, Eduardus F M; Issa, Djamila E; Visser, Hein P J; Bellido, Mar; Kutsch, Nadine; Dürig, Jan; Stehle, Alexander; Vöhringer, Matthias; Böttcher, Sebastian; Schulte, Clemens; Simon, Florian; Fink, Anna-Maria; Fischer, Kirsten; Holmes, Emily E; Kreuzer, Karl-Anton; Ritgen, Matthias; Brüggemann, Monika; Tausch, Eugen; Stilgenbauer, Stephan; Hallek, Michael; Niemann, Carsten U; Eichhorst, Barbara
    First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13) : 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
    In: The Lancet Oncology , Jg. 25 2024, Nr. 6, S. 744 – 759
    DOI (Open Access)
  • Mai, Elias K.; Hielscher, Thomas; Bertsch, Uta; Salwender, Hans J.; Zweegman, Sonja; Raab, Marc S.; Munder, Markus; Pantani, Lucia; Mancuso, Katia; Brossart, Peter; Beksac, Meral; Blau, Igor W.; Dürig, Jan; Besemer, Britta; Fenk, Roland; Reimer, Peter; van der Holt, Bronno; Hänel, Mathias; von Metzler, Ivana; Graeven, Ullrich; Müller-Tidow, Carsten; Boccadoro, Mario; Scheid, Christof; Dimopoulos, Meletios A.; Hillengass, Jens; Weisel, Katja C.; Cavo, Michele; Sonneveld, Pieter; Goldschmidt, Hartmut
    Predictors of early morbidity and mortality in newly diagnosed multiple myeloma : Data from five randomized, controlled, phase III trials in 3700 patients
    In: Leukemia , Jg. 38 2024, Nr. 3, S. 640 – 647
    DOI (Open Access)
  • Kriegsmann, Katharina; Manta, Calin; Schwab, Ricarda; Mai, Elias K.; Raab, Marc S.; Salwender, Hans J.; Fenk, Roland; Besemer, Britta; Dürig, Jan; Schroers, Roland; von Metzler, Ivana; Hänel, Mathias; Mann, Christoph; Asemissen, Anne M.; Heilmeier, Bernhard; Bertsch, Uta; Huhn, Stefanie; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Hundemer, Michael
    Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM
    In: Blood Advances , Jg. 7 2023, Nr. 3, S. 379 – 383
    DOI (Open Access)
  • Huber, Henriette; Tausch, Eugen; Schneider, Christof; Edenhofer, Simone; von Tresckow, Julia; Robrecht, Sandra; Giza, Adam; Zhang, Can; Fürstenau, Moritz; Dreger, Peter; Ritgen, Matthias; Illmer, Thomas; Illert, Anna Lena; Dürig, Jan; Böttcher, Sebastian; Niemann, Carsten U.; Kneba, Michael; Al-Sawaf, Othman; Kreuzer, Karl-Anton; Fink, Anna-Maria; Fischer, Kirsten; Döhner, Hartmut; Hallek, Michael; Eichhorst, Barbara; Stilgenbauer, Stephan
    Final analysis of the CLL2-GIVe trial : obinutuzumab, ibrutinib and venetoclax in untreated CLL with del(17p)/TP53mut
    In: Blood , Jg. 142 2023, Nr. 11, S. 961 – 972
    DOI
  • Hermine, Olivier; Jiang, Linmiao; Walewski, Jan; Bosly, André; Thieblemont, Catherine; Szymczyk, Michal; Pott, Christiane; Salles, Gilles; Feugier, Pierre; Hübel, Kai; Haioun, Corinne; Casasnovas, René Olivier; Schmidt, Christian; Bouabdallah, Kamal; Ribrag, Vincent; Kanz, Lothar; Dürig, Jan; Metzner, Bernd; Sibon, David; Cheminant, Morgane; Burroni, Barbara; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva; Dreyling, Martin
    High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma : Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network
    In: Journal of Clinical Oncology (JCO) , Jg. 41 2023, Nr. 3, S. 479 – 484
    DOI
  • Johansson, Patricia; Alig, Stefan; Richter, Julia; Hanoun, Christine; Rekowski, Jan; Dürig, Jan; Ylstra, Bauke; de Jong, Daphne; Klapper, Wolfram; Alizadeh, Ash A.; Dührsen, Ulrich; Hüttmann, Andreas
    Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma
    In: Annals of Hematology , Jg. 102 2023, Nr. 12, S. 3445 – 3455
    DOI (Open Access)
  • Johansson, Patricia; Laguna, Teresa; Ossowski, Julio; Pancaldi, Vera; Brauser, Martina; Dührsen, Ulrich; Keuneke, Lara; Queiros, Ana; Richter, Julia; Martín-Subero, José I.; Siebert, Reiner; Schlegelberger, Brigitte; Küppers, Ralf; Dürig, Jan; Penas, Eva M. Murga; Pau, Enrique Carrillo-de Santa; Bergmann, Anke K.
    Publisher Correction: Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
    In: Clinical Epigenetics , Jg. 15 2023, Nr. 1, 3
    DOI (Open Access)
  • Baak, Lisa; Frank, Mirjam; Dürig, Jan; Dührsen, Ulrich; Hoffmann, Per; Nöthen, Markus M.; Dragano, Nico; Erbel, Raimund; Jöckel, Karl-Heinz; Schmidt, Börge
    A genetic risk score of alleles related to MGUS interacts with socioeconomic position in a population-based cohort
    In: Scientific Reports , Jg. 12 2022, Nr. 1, 4409
    DOI, Online Volltext (Open Access)
  • Goldschmidt, Hartmut; Mai, Elias K.; Bertsch, Uta; Fenk, Roland; Nievergall, Eva; Tichy, Diana; Besemer, Britta; Dürig, Jan; Schroers, Roland; von Metzler, Ivana; Hänel, Mathias; Mann, Christoph; Asemissen, Anne M.; Heilmeier, Bernhard; Weinhold, Niels; Huhn, Stefanie; Kriegsmann, Katharina; Luntz, Steffen P.; Holderried, Tobias A W; Trautmann-Grill, Karolin; Gezer, Deniz; Klaiber-Hakimi, Maika; Müller, Martin; Khandanpour, Cyrus; Knauf, Wolfgang; Scheid, Christof; Munder, Markus; Geer, Thomas; Riesenberg, Hendrik; Thomalla, Jörg; Hoffmann, Martin; Raab, Marc S.; Salwender, Hans J.; Weisel, Katja C.; Ziske, Carsten; German-Speaking Myeloma Multicenter Group (GMMG) HD7 investigators (Hrsg.)
    Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7) : Part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial
    In: The Lancet Haematology , Jg. 9 2022, Nr. 11, S. e810 – e821
    DOI
  • Johansson, Patricia; Laguna, Teresa; Ossowski, Julio; Pancaldi, Vera; Brauser, Martina; Dührsen, Ulrich; Keuneke, Lara; Queiros, Ana; Richter, Julia; Martín-Subero, José I.; Siebert, Reiner; Schlegelberger, Brigitte; Küppers, Ralf; Dürig, Jan; Murga Penas, Eva M.; Carillo-de Santa Pau, Enrique; Bergmann, Anke K.
    Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
    In: Clinical Epigenetics , Jg. 14 2022, Nr. 1, 148
    DOI, Online Volltext (Open Access)
  • Denker, Sophy; Bittner, Aitomi; Frick, Mareike; Kase, Julia; Hoffmann, Jörg; Trenker, Corinna; Keller, Ulrich; Bogner, Christian; Hüttmann, Andreas; Dürig, Jan; Janz, Martin; Mathas, Stephan; Marks, Reinhard; Krohn, Ulrike; Na, Il-Kang; Bullinger, Lars; Schmitt, Clemens A.
    Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma : First analysis of toxicity and efficacy signals
    In: Leukemia and Lymphoma , Jg. 63 2022, Nr. 1, S. 84 – 92
    DOI (Open Access)
  • Huber, Henriette; Edenhofer, Simone; von Tresckow, Julia; Robrecht, Sandra; Zhang, Can; Tausch, Eugen; Schneider, Christof; Bloehdorn, Johannes; Fürstenau, Moritz; Dreger, Peter; Ritgen, Matthias; Illmer, Thomas; Illert, Anna L.; Dürig, Jan; Böttcher, Sebastian; Niemann, Carsten U.; Kneba, Michael; Fink, Anna-Maria; Fischer, Kirsten; Döhner, Hartmut; Hallek, Michael; Eichhorst, Barbara; Stilgenbauer, Stephan
    Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia
    In: Blood , Jg. 139 2022, Nr. 9, S. 1318 – 1329
    DOI (Open Access)
  • Richardson, Paul G.; Schjesvold, Fredrik; Weisel, Katja; Moreau, Philippe; Anderson, Larry D.; White, Darrell; Rodriguez-Otero, Paula; Sonneveld, Pieter; Engelhardt, Monika; Jenner, Matthew; Corso, Alessandro; Dürig, Jan; Pavic, Michel; Salomo, Morten; Beksac, Meral; Oriol, Albert; Lindsay, Jindriska; Liberati, Anna Marina; Galli, Monica; Robak, Pawel; Larocca, Alessandra; Yagci, Munci; Vural, Filiz; Kanate, Abraham S.; Jiang, Ruiyun; Grote, Lara; Peluso, Teresa; Dimopoulos, Meletios
    Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma : A subanalysis of OPTIMISMM by clinical characteristics
    In: European Journal of Haematology , Jg. 108 2022, Nr. 1, S. 73 – 83
    DOI (Open Access)
  • D'Agostino, Mattia; Cairns, David A.; Lahuerta, Juan José; Wester, Ruth; Bertsch, Uta; Waage, Anders; Zamagni, Elena; Mateos, María-Victoria; Dall'olio, Daniele; Van De Donk, Niels W.C.J.; Jackson, Graham; Rocchi, Serena; Salwender, Hans; Bladé Creixenti, Joan; Van Der Holt, Bronno; Castellani, Gastone; Bonello, Francesca; Capra, Andrea; Mai, Elias K.; Dürig, Jan; Gay, Francesca; Zweegman, Sonja; Cavo, Michele; Kaiser, Martin F.; Goldschmidt, Hartmut; Hernández Rivas, Jesús María; Larocca, Alessandra; Cook, Gordon; San-Miguel, Jesús F.; Boccadoro, Mario; Sonneveld, Pieter
    Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma : A European Myeloma Network (EMN) Report Within the HARMONY Project
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 29, S. 3406 – 3418
    DOI (Open Access)
  • Dürig, Jan; Uhlig, Jens; Gerhardt, Anke; Ritter, Markus; Hapke, Gunnar; Heßling, Jörg; Staib, Peter; Wolff, Frieder; Krumm, Katja; Fischer von Weikersthal, Ludwig
    Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma : Final results of the non‐interventional study MabSCale
    In: Cancer Medicine , Jg. 12 2022, Nr. 3, S. 2739 – 2751
    DOI, Online Volltext (Open Access)
  • Patil, Paurnima; Hillebrecht, Sina; Chteinberg, Emil; López Macias, Cristina; Toprak, Umut H.; Seufert, Julian; Bernhart, Stephan H.; Kretzmer, Helene; Bergmann, Anke K.; Bens, Susanne; Högel, Josef; Müller, Annika; Jebaraj, Billy Michael; Schrader, Alexandra; Johansson, Patricia; Costa, Dolors; Schlesner, Matthias; Dürig, Jan; Herling, Marco; Campo, Elias; Stilgenbauer, Stephan; Wiehle, Laura; Siebert, Reiner
    T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level
    In: Genes, Chromosomes and Cancer , Jg. 61 2022, Nr. 7, S. 432 – 436
    DOI, Online Volltext (Open Access)
  • Ohlwein, Simone; Hennig, Frauke; Lucht, Sarah; Schmidt, Börge; Eisele, Lewin; Arendt, Marina; Dührsen, Ulrich; Dürig, Jan; Jöckel, Karl-Heinz; Moebus, Susanne; Hoffmann, Barbara
    Air pollution and polyclonal elevation of serum free light chains : An assessment of adaptive immune responses in the prospective heinz nixdorf recall study
    In: Environmental Health Perspectives , Jg. 129 2021, Nr. 2, S. 027004
    DOI (Open Access)
  • Cramer, Paula; von Tresckow, Julia; Robrecht, Sandra; Bahlo, Jasmin; Fürstenau, Moritz; Langerbeins, Petra; Pflug, Natali; Al-Sawaf, Othman; Heinz, Werner J.; Vehling-Kaiser, Ursula; Dürig, Jan; Tausch, Eugen; Hensel, Manfred; Sasse, Stephanie; Fink, Anna-Maria; Fischer, Kirsten; Kreuzer, Karl-Anton; Böttcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
    Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia : Primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)
    In: Haematologica / The Hematology Journal , Jg. 106 2021, Nr. 2, S. 543 – 554
    DOI (Open Access)
  • Mai, Elias K.; Miah, Kaya; Bertsch, Uta; Dürig, Jan; Scheid, Christof; Weisel, Katja C.; Kunz, Christina; Munder, Markus; Lindemann, Hans-Walter; Merz, Maximilian; Hose, Dirk; Jauch, Anna; Seckinger, Anja; Luntz, Steffen; Sauer, Sandra; Fuhrmann, Stephan; Brossart, Peter; Elmaagacli, Ahmet; Goerner, Martin; Bernhard, Helga; Hoffmann, Martin; Raab, Marc S.; Blau, Igor W.; Hänel, Mathias; Benner, Axel; Salwender, Hans J.; Goldschmidt, Hartmut
    Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
    In: Leukemia , Jg. 35 2021, Nr. 3, S. 809 – 822
    DOI (Open Access)
  • Budeus, Bettina; Kibler, Artur; Brauser, Martina; Homp, Ekaterina; Bronischewski, Kevin; Ross, J. Alexander; Görgens, Andre; Weniger, Marc; Dunst, Josefine; Kreslavsky, Taras; da Conceição Castro, Symone Vitoriano; Murke, Florian; Oakes, Christopher C.; Rusch, Peter; Andrikos, Dimitrios; Kern, Peter; Köninger, Angela; Lindemann, Monika; Johansson, Patricia; Hansen, Wiebke; Lundell, Anna-Carin; Rudin, Anna; Dürig, Jan; Giebel, Bernd; Hoffmann, Daniel; Küppers, Ralf; Seifert, Marc
    Human cord blood b cells differ from the adult counterpart by conserved ig repertoires and accelerated response dynamics
    In: The Journal of Immunology (JI) , Jg. 206 2021, Nr. 12, S. 2839 – 2851
    DOI (Open Access)
  • Oubari, Sara; Naser, Eyad; Papathanasiou, Maria; Lüdike, Peter; Hagenacker, Tim; Thimm, Andreas; Rischpler, Christoph; Kessler, Lukas; Kimmich, Christoph; Hegenbart, Ute; Schönland, Stefan; Rassaf, Tienush; Reinhardt, Hans Christian; Jöckel, Karl-Heinz; Dürig, Jan; Dührsen, Ulrich; Carpinteiro, Alexander
    Impact of time to diagnosis on Mayo stages, treatment outcome, and survival in patients with AL amyloidosis and cardiac involvement
    In: European Journal of Haematology , Jg. 107 2021, Nr. 4, S. 449 – 457
    DOI (Open Access)
  • Baertsch, Marc-Andrea; Mai, Elias K.; Hielscher, Thomas; Bertsch, Uta; Salwender, Hans J.; Munder, Markus; Fuhrmann, Stephan; Dührsen, Ulrich; Brossart, Peter; Neben, Kai; Schlenzka, Jana; Kunz, Christina; Raab, Marc S.; Hillengaß, Jens; Jauch, Anna; Seckinger, Anja; Hose, Dirk; Luntz, Steffen; Sonneveld, Pieter; Lokhorst, Henk; Martin, Hans; Goerner, Martin; Hoffmann, Martin; Lindemann, Hans-Walter; Bernhard, Helga; Blau, Igor W.; Scheid, Christof; Besemer, Britta; Weisel, Katja C.; Hänel, Mathias; Dürig, Jan; Goldschmidt, Hartmut
    Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
    In: Blood Cancer Journal , Jg. 11 2021, Nr. 1, S. 1
    DOI (Open Access)
  • Salwender, Hans; Elmaagacli, Ahmet; Merz, Maximilian; Miah, Kaya; Benner, Axel; Haenel, Mathias; Jehn, Christian; Mai, Elias K.; Bertsch, Uta; Blau, Igor W.; Scheid, Christof; Hose, Dirk; Seckinger, Anja; Jauch, Anna; Raab, Marc S.; Luntz, Steffen P.; Besemer, Britta; Munder, Markus; Brossart, Peter; Fuhrmann, Stephan; Lindemann, Hans-Walter; Weisel, Katja; Duerig, Jan; Goldschmidt, Hartmut
    Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial
    In: Leukemia 2021
    DOI
  • Hornung, Nicola; Frank, Mirjam; Dragano, Nico; Dürig, Jan; Dührsen, Ulrich; Moebus, Susanne; Erbel, Raimund; Stang, Andreas; Jöckel, Karl-Heinz; Schmidt, Börge
    Monoclonal gammopathy of undetermined significance is associated with prostate cancer in a population-based cohort study
    In: Scientific Reports , Jg. 11 2021, Nr. 1, 19266
    DOI, Online Volltext (Open Access)
  • Klein, Eva-Maria; Tichy, Diana; Salwender, Hans J.; Mai, Elias K.; Dürig, Jan; Weisel, Katja C.; Benner, Axel; Bertsch, Uta; Akhavanpoor, Mabast; Besemer, Britta; Munder, Markus; Lindemann, Hans-Walter; Hose, Dirk; Seckinger, Anja; Luntz, Steffen; Jauch, Anna; Elmaagacli, Ahmet; Fuhrmann, Stephan; Brossart, Peter; Goerner, Martin; Bernhard, Helga; Raab, Marc S.; Blau, Igor W.; Haenel, Mathias; Scheid, Christof; Goldschmidt, Hartmut
    Prognostic impact of serum free light chain ratio normalization in patients with multiple myeloma treated within the GMMG-MM5 trial
    In: Cancers , Jg. 13 2021, Nr. 19, 4856
    DOI (Open Access)
  • Subramaniam, Nirojah; Bottek, Jenny; Thiebes, Stephanie; Zec, Kristina; Kudla, Matthias; Soun, Camille; De Dios Panal, Elena; Lill, Julia K.; Pfennig, Aaron; Herrmann, Ralf; Bruderek, Kirsten; Rahmann, Sven; Brandau, Sven; Johansson, Patricia; Reinhardt, Hans Christian; Dürig, Jan; Seiffert, Martina; Bracht, Thilo; Sitek, Barbara; Engel, Daniel Robert
    Proteomic and bioinformatic profiling of neutrophils in CLL reveals functional defects that predispose to bacterial infections
    In: Blood Advances , Jg. 5 2021, Nr. 5, S. 1259 – 1272
    DOI (Open Access)
  • Mai, Elias K.; Miah, Kaya; Bertsch, Uta; Dürig, Jan; Scheid, Christof; Weisel, Katja C.; Kunz, Christina; Munder, Markus; Lindemann, Hans-Walter; Merz, Maximilian; Hose, Dirk; Jauch, Anna; Seckinger, Anja; Luntz, Steffen; Sauer, Sandra; Fuhrmann, Stephan; Brossart, Peter; Elmaagacli, Ahmet; Goerner, Martin; Bernhard, Helga; Hoffmann, Martin; Raab, Marc S.; Blau, Igor W.; Hänel, Mathias; Benner, Axel; Salwender, Hans J.; Goldschmidt, Hartmut
    Publisher Correction : Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
    In: Leukemia , Jg. 35 2021, Nr. 12, S. 3636
    DOI (Open Access)
  • Al-Sawaf, O.; Robrecht, S.; Bahlo, J.; Fink, A.M.; Cramer, P.; v Tresckow, J.; Lange, E.; Kiehl, M.; Dreyling, M.; Ritgen, M.; Dürig, Jan; Tausch, E.; Schneider, C.; Stilgenbauer, S.; Wendtner, C.M.; Fischer, K.; Goede; Hallek, M.; Eichhorst, B.
    Richter transformation in chronic lymphocytic leukemia (CLL) : a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
    In: Leukemia , Jg. 35 2021, Nr. 1, S. 169 – 176
    DOI
  • Awwad, Mohamed H. S.; Mahmoud, Abdelrahman; Bruns, Heiko; Echchannaoui, Hakim; Kriegsmann, Katharina; Lutz, Raphael; Raab, Marc S.; Bertsch, Uta; Munder, Markus; Jauch, Anna; Weisel, Katja; Maier, Bettina; Weinhold, Niels; Salwender, Hans Jürgen; Eckstein, Volker; Hänel, Mathias; Fenk, Roland; Dürig, Jan; Brors, Benedikt; Benner, Axel; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Hundemer, Michael
    Selective elimination of immunosuppressive T cells in patients with multiple myeloma
    In: Leukemia , Jg. 35 2021, Nr. 9, S. 2602 – 2615
    DOI (Open Access)
  • Johansson, Patricia; Dierichs, Laura; Klein-Hitpaß, Ludger; Bergmann, Anke K.; Möllmann, Michael; Menninger, Sascha; Habenberger, Peter; Klebl, Bert; Siveke, Jens; Dührsen, Ulrich; Choidas, Axel; Dürig, Jan
    Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia
    In: Therapeutic Advances in Hematology , Jg. 11 2020, S. 1 – 15
    DOI, Online Volltext (Open Access)
  • Dampmann, Maria; Görgens, André; Möllmann, Michael; Murke, Florian; Dührsen, Ulrich; Giebel, Bernd; Dürig, Jan
    CpG stimulation of chronic lymphocytic leukemia cells induces a polarized cell shape and promotes migration in vitro and in vivo
    In: PLoS ONE , Jg. 15 2020, Nr. 2, S. e0228674
    DOI (Open Access)
  • Johansson, Patricia; Klein-Hitpaß, Ludger; Budeus, Bettina; Kuhn, Matthias; Lauber, Chris; Seifert, Michael; Roeder, Ingo; Pförtner, Roman; Stuschke, Martin; Dührsen, Ulrich; Eckstein, Anja; Dürig, Jan; Küppers, Ralf
    Identifying genetic lesions in ocular adnexal extranodal marginal zone lymphomas of the malt subtype by whole genome, whole exome and targeted sequencing
    In: Cancers , Jg. 12 2020, Nr. 4, 986
    DOI, Online Volltext (Open Access)
  • Johansson, Patricia; Klein-Hitpaß, Ludger; Röth, Alexander; Möllmann, Michael; Reinhardt, Hans Christian; Dührsen, Ulrich; Dürig, Jan
    Mutations in PIGA cause a CD52-/GPI-anchor-deficient phenotype complicating alemtuzumab treatment in T-cell prolymphocytic leukemia
    In: European Journal of Haematology , Jg. 105 2020, Nr. 6, S. 786 – 796
    DOI (Open Access)
  • Oberbeck, S.; Schrader, A.; Warner, K.; Jungherz, D.; Crispatzu, G.; von Jan, J.; Chmielewski, M.; Ianevski, A.; Diebner, H.H.; Mayer, P.; Ados, A. Kondo; Wahnschaffe, L.; Braun, T.; Müller, T.A.; Wagle, P.; Bouska, A.; Neumann, T.; Pützer, S.; Varghese, L.; Pflug, N.; Thelen, M.; Makalowski, J.; Riet, N.; Göx, H.J.M.; Rappl, G.; Altmüller, J.; Kotrová, M.; Persigehl, T.; Hopfinger, G.; Hansmann, M.L.; Schlößer, H.; Stilgenbauer, S.; Dürig, Jan; Mougiakakos, D.; von Bergwelt-Baildon, M.; Roeder, I.; Hartmann, S.; Hallek, M.; Moriggl, R.; Brüggemann, M.; Aittokallio, T.; Iqbal, J.; Newrzela, S.; Abken, H.; Herling, M.
    Noncanonical effector functions of the T-memory–like T-PLL cell are shaped by cooperative TCL1A and TCR signaling
    In: Blood , Jg. 136 2020, Nr. 24, S. 2786 – 2802
    DOI (Open Access)
  • Patil, Paurnima; Cieslak, Agata; Bernhart, Stephan H.; Toprak, Umut H.; Wagener, Rabea; López, Cristina; Wiehle, Laura; Bens, Susanne; Altmüller, Janine; Franitza, Marek; Scholz, Ingrid; Jayne, Sandrine; Ahearne, Matthew J.; Scheffold, Annika; Jebaraj, Billy M. C.; Schneider, Christof; Costa, Dolors; Braun, Till; Schrader, Alexandra; Campo, Elias; Dyer, Martin J. S.; Nürnberg, Peter; Dürig, Jan; Johansson, Patricia; Böttcher, Sebastian; Schlesner, Matthias; Herling, Marco; Stilgenbauer, Stephan; Macintyre, Elizabeth; Siebert, Reiner
    Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia
    In: Genes, Chromosomes and Cancer , Jg. 59 2020, Nr. 4, S. 261 – 267
    DOI (Open Access)
  • Goldschmidt, Hartmut; Mai, Elias K.; Dürig, Jan; Scheid, Christof; Weisel, Katja C.; Kunz, Christina; Bertsch, Uta; Hielscher, Thomas; Merz, Maximilian; Munder, Markus; Lindemann, Hans-Walter; Hügle-Dörr, Barbara; Tichy, Diana; Giesen, Nicola; Hose, Dirk; Seckinger, Anja; Huhn, Stefanie; Luntz, Steffen; Jauch, Anna; Elmaagacli, Ahmet; Rabold, Bernhard; Fuhrmann, Stephan; Brossart, Peter; Goerner, Martin; Bernhard, Helga; Hoffmann, Martin; Hillengass, Jens; Raab, Marc S.; Blau, Igor W.; Hänel, Mathias; Salwender, Hans J.
    Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial
    In: Leukemia , Jg. 34 2020, Nr. 7, S. 1853 – 1865
    DOI
  • Weisel, Katja C.; Scheid, Christof; Zago, Manola; Besemer, Britta; Mai, Elias K.; Haenel, Mathias; Dürig, Jan; Munder, Markus; Lindemann, Hans-Walter; Seckinger, Anja; Kunz, Christina; Benner, Axel; Hose, Dirk; Jauch, Anna; Salwender, Hans; Goldschmidt, Hartmut
    Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone : results of the phase II PERSPECTIVE Multiple Myeloma trial
    In: Blood Cancer Journal , Jg. 9 2019, Nr. 4, S. 45
    DOI (Open Access)
  • Kriegsmann, Katharina; Baertsch, Marc-Andrea; Awwad, Mohamed H. S.; Merz, Maximilian; Hose, Dirk; Seckinger, Anja; Jauch, Anna; Becker, Natalia; Benner, Axel; Raab, Marc S.; Hillengass, Jens; Bertsch, Uta; Dürig, Jan; Salwender, Hans Jürgen; Hänel, Mathias; Fenk, Roland; Munder, Markus; Weisel, Katja; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Hundemer, Michael
    Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients
    In: Blood Cancer Journal , Jg. 9 2019, Nr. 2, S. 13
    DOI (Open Access)
  • Leeksma, Alexander C.; Taylor, Justin; Wu, Bian; Gardner, Jeffrey R.; He, Jie; Nahas, Michelle; Gonen, Mithat; Alemayehu, Wendimagegn G.; te Raa, Doreen; Walther, Tatjana; Hüllein, Jennifer; Dietrich, Sascha; Claus, Rainer; de Boer, Fransien; de Heer, Koen; Dubois, Julie; Dampmann, Maria; Dürig, Jan; van Oers, Marinus H. J.; Geisler, Christian H.; Eldering, Eric; Levine, Ross L.; Miller, Vincent; Mughal, Tariq; Lamanna, Nicole; Frattini, Mark G.; Heaney, Mark L.; Zelenetz, Andrew; Zenz, Thorsten; Abdel-Wahab, Omar; Kater, Arnon P.
    Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia
    In: Leukemia , Jg. 33 2019, Nr. 2, S. 390 – 402
    DOI (Open Access)
  • Merz, Maximilian; Hielscher, Thomas; Mai, Elias Karl; Seckinger, Anja; Hose, Dirk; Jauch, Anna; Sauer, Sandra; Luntz, Steffen; Bertsch, Uta; Raab, Marc S.; Neben, Kai; Salwender, Hans; Blau, Igor W.; Lindemann, Hans-Walter; Dürig, Jan; Scheid, Christof; Haenel, Mathias; Weisel, Katja; Weber, Tim; Delorme, Stefan; Goldschmidt, Hartmut; Hillengass, Jens
    Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma
    In: Blood Cancer Journal , Jg. 9 2019, Nr. 9, S. 71
    DOI (Open Access)
  • Radtke, Stefan; Görgens, André; Vitoriano da Conceição Castro, Symone; Kordelas, Lambros; Köninger, Angela; Dürig, Jan; Möllmann, Michael; Horn, Peter; Giebel, Bernd
    Human multipotent hematopoietic progenitor cell expansion is neither supported in endothelial and endothelial/mesenchymal co-cultures nor in NSG mice
    In: Scientific Reports , Jg. 9 2019, S. 12914
    DOI, Online Volltext (Open Access)
  • Wahnschaffe, Linus; Braun, Till; Timonen, Sanna; Giri, Anil K.; Schrader, Alexandra; Wagle, Prerana; Almusa, Henrikki; Johansson, Patricia; Bellanger, Dorine; López, Cristina; Haferlach, Claudia; Stern, Marc-Henri; Dürig, Jan; Siebert, Reiner; Mustjoki, Satu; Aittokallio, Tero; Herling, Marco
    JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL
    In: Cancers , Jg. 11 2019, Nr. 12, S. 1833
    DOI (Open Access)
  • Pflug, Natali; Cramer, Paula; Robrecht, Sandra; Bahlo, Jasmin; Westermann, Anne; Fink, Anna-Maria; Schrader, Alexandra; Mayer, Petra; Oberbeck, Sebastian; Seiler, Till; Zenz, Thorsten; Dürig, Jan; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Herling, Marco; Hopfinger, Georg
    New lessons learned in T-PLL : results from a prospective phase-II trial with fludarabine–mitoxantrone–cyclophosphamide–alemtuzumab induction followed by alemtuzumab maintenance
    In: Leukemia and Lymphoma , Jg. 60 2019, Nr. 3, S. 649 – 657
    DOI
  • Haas, Eva-Maria; Salwender, Hans J.; Mai, Elias K.; Dürig, Jan; Weisel, Katja; Tichy, Diana; Benner, Axel; Kunz, Christina; Hielscher, Thomas; Bertsch, Uta; Besemer, Britta; Merz, Maximilian; Munder, Markus; Lindemann, Hans-Walter; Hügle-Dörr, Barbara; Giessen, Nicola; Hose, Dirk; Seckinger, Anja; Huhn, Stefanie; Luntz, Steffen; Jauch, Anna; Elmaagacli, Ahmet; Rabold, Bernhard; Fuhrmann, Stephan; Brossart, Peter; Goerner, Martin; Bernhard, Helga; Hoffmann, Martin; Hillengass, Jens; Raab, Marc S.; Blau, Igor Wolfgang; Haenel, Mathias; Scheid, Christof; Goldschmidt, Hartmut
    Normalization of serum free light chains during therapy in the MM5 trial predicts prolonged progression free survival and overall survival
    17th International Myeloma Workshop ; September 12-15, 2019, Boston, MA, USA,
    In: Clinical Lymphoma, Myeloma & Leukemia , Jg. 19 2019, Nr. 10, Suppl., S. e208
    DOI
  • Salwender, Hans; Bertsch, Uta; Weisel, Katja; Dürig, Jan; Kunz, Christina; Benner, Axel; Blau, Igor W.; Raab, Marc Steffen; Hillengass, Jens; Hose, Dirk; Huhn, Stefanie; Hundemer, Michael; Andrulis, Mindaugas; Jauch, Anna; Seidel-Glaetzer, Andrea; Lindemann, Hans-Walter; Hensel, Manfred; Fronhoffs, Stefan; Martens, Uwe; Hansen, Timon; Wattad, Mohammed; Graeven, Ullrich; Munder, Markus; Fenk, Roland; Haenel, Mathias; Scheid, Christof; Goldschmidt, Hartmut
    Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6 : A randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma
    In: BMC Cancer , Jg. 19 2019, Nr. 1, S. 504
    DOI (Open Access)
  • Hüttmann, Andreas; Rekowski, Jan; Müller, Stefan; Hertenstein, Bernd; Franzius, Christiane; Mesters, Rolf; Weckesser, Matthias; Kroschinsky, Frank; Kotzerke, Jörg; Ganser, Arnold; Bengel, Frank M.; La Rosée, Paul; Freesmeyer, Martin; Höffkes, Heinz-Gert; Hertel, Andreas; Behringer, Dirk; Prange-Krex, Gabriele; Griesshammer, Martin; Holzinger, Jens; Wilop, Stefan; Krohn, Thomas; Raghavachar, Aruna; Maschmeyer, Georg; Brink, Ingo; Schroers, Roland; Gaska, Tobias; Bernhard, Helga; Giagounidis, Aristoteles; Schütte, Jochen; Dienst, Ariane; Hautzel, Hubertus; Naumann, Ralph; Klein, Alfred; Hahn, Dennis; Pöpperl, Gabriele; Grube, Matthias; Marienhagen, Jörg; Schwarzer, Andreas; Kurch, Lars; Höhler, Thomas; Steiniger, Heike; Nückel, Holger; Südhoff, Thomas; Römer, Wolfgang; Brinkmann, Marcus; Ose, Claudia; Alashkar, Ferras; Schmitz, Christine; Dürig, Jan; Hoelzer, Dieter; Jöckel, Karl-Heinz; Klapper, Wolfram; Dührsen, Ulrich
    Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP : results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial
    In: Annals of Hematology , Jg. 98 2019, Nr. 4, S. 897 – 907
    DOI
  • Schmidt, Börge; Debold, Elisabeth; Frank, Mirjam; Arendt, Marina; Dragano, Nico; Dürig, Jan; Dührsen, Ulrich; Moebus, Susanne; Erbel, Raimund; Jöckel, Karl-Heinz; Eisele, Lewin
    Socioeconomic Position is Positively Associated with Monoclonal Gammopathy of Undetermined Significance in a Population-based Cohort Study
    In: Annals of Hematology , Jg. 98 2019, Nr. 12, S. 2761 – 2767
    DOI
  • König, Laila; Dreyling, Martin; Dürig, Jan; Engelhard, Marianne; Hohloch, Karin; Viardot, Andreas; Witzens-Harig, Mathias; Kieser, Meinhard; Klapper, Wolfram; Pott, Christiane; Herfarth, Klaus
    Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy) : A study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial
    In: Trials , Jg. 20 2019, Nr. 1, S. 544
    DOI (Open Access)
  • Tucci, Felicia A.; Kitanovski, Simo; Johansson, Patricia; Klein-Hitpaß, Ludger; Kahraman, Alisan; Dürig, Jan; Hoffmann, Daniel; Küppers, Ralf
    Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus–infected individuals
    In: Blood , Jg. 131 2018, Nr. 5, S. 546 – 557
    DOI (Open Access)
  • Dietrich, Sascha; Oleś, Małgorzata; Lu, Junyan; Sellner, Leopold; Anders, Simon; Velten, Britta; Wu, Bian; Hüllein, Jennifer; Liberio, Michelle da Silva; Walther, Tatjana; Wagner, Lena; Rabe, Sophie; Ghidelli-Disse, Sonja; Bantscheff, Marcus; Oleś, Andrzej K.; Słabicki, Mikołaj; Mock, Andreas; Oakes, Christopher C.; Wang, Shihui; Oppermann, Sina; Lukas, Marina; Kim, Vladislav; Sill, Martin; Benner, Axel; Jauch, Anna; Sutton, Lesley Ann; Young, Emma; Rosenquist, Richard; Liu, Xiyang; Jethwa, Alexander; Lee, Kwang Seok; Lewis, Joe; Putzker, Kerstin; Lutz, Christoph; Rossi, Davide; Mokhir, Andriy; Oellerich, Thomas; Zirlik, Katja; Herling, Marco; Nguyen-Khac, Florence; Plass, Christoph; Andersson, Emma; Mustjoki, Satu; Von Kalle, Christof; Ho, Anthony D.; Hensel, Manfred; Dürig, Jan; Ringshausen, Ingo; Zapatka, Marc; Huber, Wolfgang; Zenz, Thorsten
    Drug-perturbation-based stratification of blood cancer
    In: The Journal of Clinical Investigation (JCI) , Jg. 128 2018, Nr. 1, S. 427 – 445
    DOI (Open Access)
  • Balser, Christina; Lerchenmüller, Christian; Koenigsmann, Michael; Maschmeyer, Georg; Kaiser, Ulrich; Lange, Elisabeth; Behringer, Dirk; Kauff, Frank; Dürig, Jan; Greil, Richard; Barth, Juergen; Gaska, Tobias; Burchardt, Alexander C.; Reeb, Manfred; Rummel, Mathias; Hertenstein, Bernd; Buske, Christian; Schliesser, Georg; Hinke, Axel
    Four versus Two Years of Rituximab Maintenance (R-Maintenance) Following Bendamustine Plus Rituximab (B-R) : Results of a Prospective, Randomized Multicenter Phase 3 Study in First-Line Follicular Lymphoma (the StiL NHL7-2008 MAINTAIN Study)
    Society of Hematologic Oncology 6th Annual Meeting (SOHO) ; September 12-15, 2018, Houston, Texas, USA,
    In: Clinical Lymphoma, Myeloma & Leukemia , Jg. 18 2018, Nr. Suppl. 1, S. S101 – S103
    DOI
  • Hiddemann, Wolfgang; Barbui, Anna Maria; Canales, Miguel A.; Cannell, Paul K.; Collins, Graham P.; Dürig, Jan; Forstpointner, Roswitha; Herold, Michael; Hertzberg, Mark; Klanova, Magdalena; Radford, John; Seymour, John F.; Tobinai, Kensei; Trotman, Judith; Burciu, Alis; Fingerle-Rowson, Günter; Wolbers, Marcel; Nielsen, Tina; Marcus, Robert E.
    Immunochemotherapy with obinutuzumab or rituximab for previously untreated follicular lymphoma in the GALLIUM study : Influence of chemotherapy on efficacy and safety
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. 23, S. 2395 – 2404
    DOI (Open Access)
  • Pelzer, Benedikt W.; Arendt, Marina; Moebus, Susanne; Eisele, Lewin; Jöckel, Karl-Heinz; Dührsen, Ulrich; Dürig, Jan
    Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis
    In: Annals of Hematology , Jg. 97 2018, Nr. 8, S. 1463 – 1469
    DOI
  • Merz, Maximilian; Hielscher, T.; Seckinger, A.; Jauch, A.; Bertsch, U.; Raab, M.S.; Neben, K.; Salwender, H.; Blau, I.W.; Lindemann, H.W.; Dürig, Jan; Scheid, C.; Haenel, M.; Weisel, K.; Delorme, S.; Kauczor, H.U.; Hose, D.; Goldschmidt, H.; Hillengass, J.
    Magnetic resonance imaging before and after upfront autologous transplantation identifies patients with adverse outcome but response to treatment within the prospective GMMG MM5 phase III trial
    In: Haematologica / The Hematology Journal , Jg. 103 2018, Nr. Suppl. 1, S. 11 – 12
  • Mangolini, Maurizio; Götte, Frederik; Moore, Andrew; Ammon, Tim; Oelsner, Madlen; Lutzny-Geier, Gloria; Klein-Hitpaß, Ludger; Williamson, James C.; Lehner, Paul J.; Dürig, Jan; Möllmann, Michael; Rásó-Barnett, Lívia; Hughes, Katherine; Santoro, Antonella; Méndez-Ferrer, Simón; Oostendorp, Robert A. J.; Zimber-Strobl, Ursula; Peschel, Christian; Hodson, Daniel J.; Schmidt-Supprian, Marc; Ringshausen, Ingo
    Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia
    In: Nature Communications , Jg. 9 2018, 3839
    DOI (Open Access)
  • Dührsen, Ulrich; Müller, Stefan; Hertenstein, Bernd; Thomssen, Henrike; Kotzerke, Jörg; Mesters, Rolf; Berdel, Wolfgang E.; Franzius, Christiane; Kroschinsky, Frank; Weckesser, Matthias; Kofahl-Krause, Dorothea; Bengel, Frank M.; Dürig, Jan; Matschke, Johannes; Schmitz, Christine; Pöppel, Thorsten; Ose, Claudia; Brinkmann, Marcus; La Rosée, Paul; Freesmeyer, Martin; Hertel, Andreas; Höffkes, Heinz-Gert; Behringer, Dirk; Prange-Krex, Gabriele; Wilop, Stefan; Krohn, Thomas; Holzinger, Jens; Griesshammer, Martin; Giagounidis, Aristoteles; Raghavachar, Aruna; Maschmeyer, Georg; Brink, Ingo; Bernhard, Helga; Haberkorn, Uwe; Gaska, Tobias; Kurch, Lars; Van Assema, Daniëlle M.E.; Klapper, Wolfram; Hoelzer, Dieter; Geworski, Lilli; Jöckel, Karl-Heinz; Scherag, Andre; Bockisch, Andreas; Rekowski, Jan; Hüttmann, Andreas
    Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) : A Multicenter, Randomized Phase III Trial
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. 20, S. 2024 – 2034
    DOI (Open Access)
  • Göthert, Joachim Rudolf; Imsak, Roze; Möllmann, Michael; Kesper, Stefanie; Göbel, Maria; Dührsen, Ulrich; Scholz, Arne; Lücking, Ulrich; Baumann, Matthias; Unger, Anke; Schultz-Fademrecht, Carsten; Klebl, Bert; Eickhoff, Jan; Choidas, Axel; Dürig, Jan
    Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemia
    In: OncoTarget , Jg. 9 2018, Nr. 41, S. 26353 – 26369
    DOI (Open Access)
  • Herfarth, Klaus; Borchmann, Peter; Schnaidt, Sven; Hohloch, Karin; Budach, Volker; Engelhard, Marianne; Viardot, Andreas; Engenhart-Cabillic, Rita; Keller, Ulrich; Reinartz, Gabriele; Eich, Hans-Theodor; Witzens-Harig, Mathias; Hess, Clemens F.; Dörken, Bernd; Dürig, Jan; Wiegel, Thomas; Hiddemann, Wolfgang; Hoster, Eva; Pott, Christiane; Dreyling, Martin
    Rituximab with Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma : Results of the MIR Study
    In: HemaSphere: Open Access Journal of the European Hematology Association , Jg. 2 2018, Nr. 6, S. e160
    DOI (Open Access)
  • Johansson, Patricia; Klein-Hitpaß, Ludger; Choidas, Axel; Habenberger, Peter; Mahboubi, Bijan; Kim, Baek; Bergmann, Anke; Scholtysik, René; Brauser, Martina; Lollies, Anna; Siebert, Reiner; Zenz, Thorsten; Dührsen, Ulrich; Küppers, Ralf; Dürig, Jan
    SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia
    In: Blood Cancer Journal , Jg. 8 2018, Nr. 1, 11
    DOI (Open Access)
  • Awwad, Mohamed H. S.; Kriegsmann, Katharina; Plaumann, Julian; Benn, Michael; Hillengass, Jens; Raab, Marc S.; Bertsch, Uta; Munder, Markus; Weisel, Katja; Salwender, Hans Jürgen; Hänel, Mathias; Fenk, Roland; Dürig, Jan; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Hundemer, Michael
    The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma
    In: OncoImmunology , Jg. 7 2018, Nr. 10, e1486356
    DOI (Open Access)
  • Jewell, Roxanne C.; Kipps, Thomas J.; Dürig, Jan; Griskevicius, Laimonas; Stilgenbauer, Stephan; Smolej, Lukáš; Mayer, Jiří; Hess, Georg; Hernandez-Ilizaliturri, Francisco J.; Padmanabhan-Iyer, Swaminathan; Fang, Lei; Goldstein, Nancy; Gorczyca, Michele; Gupta, Ira; Lisby, Steen; Wierda, William G.
    Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy
    In: Leukemia and Lymphoma , Jg. 58 2017, Nr. 2, S. 348 – 356
    DOI (Open Access)
  • Huhn, S.; Weinhold, N.; Nickel, J.; Pritsch, M.; Hielscher, T.; Hummel, M.; Bertsch, U.; Huegle-Doerr, B.; Vogel, M.; Angermund, R.; Hänel, M.; Salwender, H.J.; Weisel, K.; Dürig, Jan; Görner, M.; Kirchner, H.; Peter, N.; Graeven, U.; Lordick, F.; Hoffmann, M.; Reimer, P.; Blau, I.W.; Jauch, A.; Dembowsky, K.; Möhler, T.; Wuchter, P.; Goldschmidt, H.
    Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial
    In: Bone Marrow Transplantation , Jg. 52 2017, Nr. 8, S. 1194 – 1198
    DOI (Open Access)
  • Schmitt, Michael; Hückelhoven, Angela G; Hundemer, Michael; Schmitt, Anita; Lipp, Susanne; Emde, Martina; Salwender, Hans; Hänel, Mathias; Weisel, Katja; Bertsch, Uta; Dürig, Jan; Ho, Anthony D.; Blau, Igor Wolfgang; Goldschmidt, Hartmut; Seckinger, Anja; Hose, Dirk
    Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trial
    In: OncoTarget , Jg. 8 2017, Nr. 49, S. 84847 – 84862
    DOI (Open Access)
  • da Silva Nardi, Fabiola; Kraemer, Thomas; Dürig, Jan; Rebmann, Vera; Wagner, Bettina; Horn, Peter; Celik, Alexander A.; Nückel, Holger; Schramm, Sabine; Dührsen, Ulrich
    HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia
    In: Cancer , Jg. 123 2017, Nr. 5, S. 814 – 823
    DOI
  • Hiddemann, W.; Barbui, A. M.; Albendea, MAC; Cannell, P. K.; Collins, G. P.; Dürig, Jan; Forstpointner, R.; Herold, M.; Hertzberg, M.; Klanova, M.; Radford, J. A.; Tobinai, K.; Burciu, A.; Fingerle-Rowson, G. R.; Nielsen, T.; Wolbers, M.; Marcus, R. E.
    Immunochemotherapy with obinutuzumab or rituximab in previously untreated follicular lymphoma in the randomized phase III gallium study : analysis by chemotherapy regimen
    In: Haematologica / The Hematology Journal , Jg. 102 2017, Nr. Suppl. 2, S. 314
  • Orban, Ester; Arendt, Marina; Hennig, Frauke; Lucht, Sarah; Eisele, Lewin; Jakobs, Hermann; Dürig, Jan; Hoffmann, Barbara; Jöckel, Karl-Heinz; Moebus, Susanne
    Is long-term particulate matter and nitrogen dioxide air pollution associated with incident monoclonal gammopathy of undetermined significance (MGUS)? : An analysis of the Heinz Nixdorf Recall study
    In: Environment International , Jg. 108 2017, S. 237 – 245
    DOI
  • Pelzer, B. W.; Arendt, Marina; Siegmund, J. M.; Eisele, Lewin; Moebus, Susanne; Jöckel, Karl-Heinz; Dührsen, Ulrich; Dürig, Jan; Heinz Nixdorf Recall Study
    Longitudinal analysis of light-chain monoclonal gammopathy of undetermined significance-10-year follow up of the population-based Heinz Nixdorf Recall study
    In: Oncology Research and Treatment , Jg. 40 2017, Nr. Suppl. 3 , S. 81 Abstract P292
    DOI
  • Mangolini, M.; Gotte, F.; Ammon, T.; Oelsner, M.; Klein-Hitpaß, Ludger; Dürig, Jan; Hughes, K.; Lutzny, G.; Strobl, U.; Ringshausen, I.
    NOTCH-signaling in the tumor microenvironment is required for canonical WNT signaling in CLL cells
    In: Leukemia and Lymphoma , Jg. 58 2017, Nr. Suppl. 1, XVII International Workshop on Chronic Lymphocytic Leukemia 2017 May 12--15, 2017, New York, S. 125 – 126
    DOI
  • Turki, Amin T.; Rashidi-Alavijeh, Jassin; Dürig, Jan; Gerken, Guido; Rath, Peter-Michael; Witzke, Oliver
    Successful treatment of cerebral aspergillosis: Case report of a patient with T-cell large granular lymphocytic leukemia (T-LGL)
    In: BMC Infectious Diseases , Jg. 17 2017, S. 797
    DOI (Open Access)
  • Haderk, Franziska; Schulz, Ralph; Iskar, Murat; Cid, Laura Llaó; Worst, Thomas; Willmund, Karolin V; Schulz, Angela; Warnken, Uwe; Seiler, Jana; Benner, Axel; Nessling, Michelle; Zenz, Thorsten; Göbel, Maria; Dürig, Jan; Diederichs, Sven; Paggetti, Jérôme; Moussay, Etienne; Stilgenbauer, Stephan; Zapatka, Marc; Lichter, Peter; Seiffert, Martina
    Tumor-derived exosomes modulate PD-L1 expression in monocytes
    In: Science Immunology , Jg. 2 2017, Nr. 13
    DOI
  • Stiefelhagen, Marius; Gigel, Carola; Vasyutina, Elena; Möllmann, Michael; Breuer, Alexandra; Mayer, Petra; Dürig, Jan; Herling, Marco
    Activity of the CD40 antagonistic antibody lucatumumab - insights from CLL-niche mimicking xenografts and fludarabine combinations
    In: Leukemia and Lymphoma , Jg. 57 2016, Nr. 9, S. 2235 – 2238
    DOI
  • Föhring, D.; Dührsen, Ulrich; Hammers, C. M.; Dürig, Jan
    Bendamustine triggered paraneoplastic pemphigus in a patient with chronic lymphocytic leukemia
    In: Oncology Research and Treatment , Jg. 39 2016, Nr. Suppl. 3, S. 257 – 258
  • Seiffert, M.; Haderk, F.; Cid, L. L.; Gobel, M.; Dürig, Jan; Lichter, P.
    Chronic Lymphocytic Leukemia-Derived Extracellular Vesicles Mediate NF kappa B Signaling and Pro-Inflammatory Cytokine Release in Monocytes
    In: The Journal of Immunology (JI) , Jg. 196 2016, Nr. Suppl. 1 , -
  • Haderk, F.; Cid, L. L.; Moussay, E.; Paggetti, J.; Willmund, K.; Seiler, Jonas; Diederichs, S.; Goebell; Dürig, Jan; Zenz, T.; Stilgenbauer, S.; Zapatka, M.; Lichter, P.; Seiffert, M.
    Chronic lymphocytic leukemia-derived extracellular vesicles mediate NFkB signaling and pro-inflammatory cytokine release in monocytes
    In: Cancer Research , Jg. 76 15 2016 , -
    DOI
  • Manteniotis, S; Wojcik, S; Göthert, Joachim Rudolf; Dürig, Jan; Dührsen, Ulrich; Gisselmann, G; Hatt, H
    Deorphanization and characterization of the ectopically expressed olfactory receptor OR51B5 in myelogenous leukemia cells
    In: Cell Death Discovery , Jg. 2 2016, Nr. 1, 16010
    DOI (Open Access)
  • Goede, Valentin; Bahlo, Jasmin; Chataline, Viktoria; Eichhorst, Barbara; Dürig, Jan; Stilgenbauer, Stephan; Kolb, Gerald; Honecker, Friedemann; Wedding, Ulrich; Hallek, Michael
    Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia : Results of the CLL9 trial of the German CLL study group
    In: Leukemia and Lymphoma , Jg. 57 2016, Nr. 4, S. 789 – 796
    DOI
  • López, Cristina; Bergmann, Anke K; Paul, Ulrike; Murga Penas, Eva M; Nagel, Inga; Betts, Matthew J; Johansson, Patricia; Ritgen, Matthias; Baumann, Tycho; Aymerich, Marta; Jayne, Sandrine; Russell, Robert B; Campo, Elias; Dyer, Martin J S; Dürig, Jan; Siebert, Reiner
    Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia
    In: British Journal of Haematology , Jg. 173 2016, Nr. 2, S. 265 – 273
    DOI
  • Bühler, A; Wendtner, C-M; Kipps, T J; Rassenti, L; Fraser, G A M; Michallet, A-S; Hillmen, P; Dürig, Jan; Gregory, S A; Kalaycio, M; Aurran-Schleinitz, T; Trentin, L; Gribben, J G; Chanan-Khan, A; Purse, B; Zhang, J; De Bedout, S; Mei, J; Hallek, M; Stilgenbauer, S
    Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia : data from the prospective, multicenter phase-II CLL-009 trial
    In: Blood Cancer Journal , Jg. 6 2016, S. e404
    DOI (Open Access)
  • Merz, Maximilian; Salwender, Hans; Haenel, Mathias; Mai, Elias K; Bertsch, Uta; Kunz, Christina; Hielscher, Thomas; Blau, Igor W; Scheid, Christof; Hose, Dirk; Seckinger, Anja; Jauch, Anna; Hillengass, Jens; Raab, Marc S; Schurich, Baerbel; Munder, Markus; Brossart, Peter; Gerecke, Christian; Lindemann, Hans-Walter; Zeis, Matthias; Weisel, Katja; Dürig, Jan; Goldschmidt, Hartmut
    Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial
    In: Haematologica / The Hematology Journal , Jg. 101 2016, Nr. 12, S. e485 – e487
    DOI (Open Access)
  • Johansson, Patricia; Bergmann, Anke; Rahmann, Sven; Wohlers, Inken; Scholtysik, René; Przekopowitz, Martina; Seifert, Marc; Tschurtschenthaler, Gertraud; Webersinke, Gerald; Jäger, Ulrich; Siebert, Reiner; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan; Küppers, Ralf
    Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia
    In: International Journal of Cancer , Jg. 138 2016, Nr. 1, S. 121 – 124
    DOI (Open Access)
  • Johansson, Patricia; Klein-Hitpaß, Ludger; Grabellus, Florian; Arnold, Georg; Klapper, Wolfram; Pförtner, Roman; Dührsen, Ulrich; Eckstein, Anja; Dürig, Jan; Küppers, Ralf
    Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas
    In: OncoTarget , Jg. 7 2016, Nr. 38, S. 62627 – 62639
    DOI (Open Access)
  • Wendtner, Clemens M.; Hallek, Michael; Fraser, Graeme A. M.; Michallet, Anne-Sophie; Hillmen, Peter; Dürig, Jan; Kalaycio, Matt; Gribben, John G.; Stilgenbauer, Stephan; Buhler, Andreas; Kipps, Thomas J.; Purse, Brendan; Zhang, Jennie; De Bedout, Sabine; Mei, Jay; Chanan-Khan, Asher
    Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial
    In: Leukemia and Lymphoma , Jg. 57 2016, Nr. 6, S. 1291 – 1299
    DOI
  • Dürig, Jan; Azeh, I.; Blumenstengel, K.; Gerhardt, A.; Hanel, M.; Hapke, G.; Hensel, M.; Hessling, J.; Hoffkes, H. G.; Hurtz, H. J.; Ritter, M.; Staib, P.; Uhlig, J.; Marquardt, M.; Krumm, K.; von Weikersthal, L. F.
    Subcutaneous rituximab in patients with DLBCL and follicular NHL - First interim results from the non-interventional study MabSCale
    In: Oncology Research and Treatment , Jg. 39 3 2016, S. 156 – 156
  • Wanger, Bettina; Nardi, FabiolaDaS; Schramm, Sabine; Kraemer, Thomas; Bade-Doeding, Christina; Dürig, Jan; Horn, Peter; Dührsen, Ulrich; Nückel, Holger; Rebmann, Vera
    Elevated levels of soluble HLA-E and the presence of HLA-E*01:03 predict disease of progression in CLL
    In: Tissue Antigens , Jg. 86 2015, Nr. 2, S. 85 – 86
  • Li, Yu; Dürig, Jan; Göbel, Maria; Hanoun, Maher; Klein-Hitpaß, Ludger; Dührsen, Ulrich
    Functional abnormalities and changes in gene expression in fibroblasts and macrophages from the bone marrow of patients with acute myeloid leukemia
    In: International Journal of Hematology , Jg. 102 2015, Nr. 3, S. 278 – 288
    DOI
  • Johansson, Patricia; Dürig, Jan; Rekowski, Jan; Muller, S. P.; Hertenstein, B.; Franzius, C.; Kroschinsky, F.; Kotzerke, J.; Mesters, R.; Weckesser, M.; La Rosee, P.; Freesmeyer, M.; Wilop, S.; Krohn, T.; Dührsen, Ulrich; Hutmann, A.
    Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive Lymphomas
    In: Blood , Jg. 126 2015, Nr. 23
  • Goergens, Andre; Ludwig, Anna-Krist; Moellmann, Michael; Krawczyk, Adalbert; Dürig, Jan; Hanenberg, Helmut; Horn, Peter A.; Giebel, Bernd
    Multipotent Hematopoietic Progenitors Divide Asymmetrically to Create Progenitors of the Lymphomyeloid and Erythromyeloid Lineages
    In: Stem Cell Reports , Jg. 5 2015, Nr. 1, S. 154 – 155
    DOI (Open Access)
  • Mai, Elias Karl; Bertsch, Uta; Dürig, Jan; Kunz, Christina; Haenel, Mathias; Blau, Igor Wolfgang; Munder, Markus; Jauch, Anna; Schurich, Baerbel; Hielscher, Thomas; Merz, Maximilian; Huegle-Doerr, B.; Seckinger, Anja; Hose, Dirk; Hillengass, Jens; Raab, Marc Steffen; Neben, Kai; Lindemann, Hans Walter; Zeis, Matthias; Gerecke, Christian; Schmidt-Wolf, Ingo G.H.; Weisel, Katja Christina; Scheid, Christof; Salwender, Hans Jürgen; Goldschmidt, Hartmut M.
    Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma
    In: Leukemia , Jg. 29 2015, Nr. 8, S. 1721 – 1729
    DOI
  • Dietrich, Sascha; Hüllein, Jennifer; Lee, Stanley Chun-Wei; Hutter, Barbara; Gonzalez, David; Jayne, Sandrine; Dyer, Martin J. S.; Oleś, Małgorzata; Else, Monica; Liu, Xiyang; Słabicki, Mikołaj; Wu, Bian; Troussard, Xavier; Dürig, Jan; Andrulis, Mindaugas; Dearden, Claire; Kalle, Christof von; Granzow, Martin; Jauch, Anna; Fröhling, Stefan; Huber, Wolfgang; Meggendorfer, Manja; Haferlach, Torsten; Ho, Anthony D.; Richter, Daniela; Brors, Benedikt; Glimm, Hanno; Matutes, Estella; Wahab, Omar Abdel; Zenz, Thorsten
    Recurrent CDKN1B (p27) mutations in hairy cell leukemia
    In: Blood , Jg. 126 2015, Nr. 8, S. 1005 – 1008
    DOI
  • Wagner, Bettina; Nardil, FabiolaDas; Schramm, Sabine; Kraemer, Thomas; Bade-Doeding, Christina; Dürig, Jan; Horn, Peter; Dührsen, Ulrich; Nückel, Holger; Rebmann, Vera
    Soluble HLA-E and HLA-E polymorphism predictors of early disease progression in CLL
    In: Tissue Antigens , Jg. 85 2015, Nr. 5, S. 327 – 328
  • Merz, Maximilian; Salwender, Hans; Haenel, Mathias; Mai, Elias K; Bertsch, Uta; Kunz, Christina; Hielscher, Thomas; Blau, Igor W; Scheid, Christof; Hose, Dirk; Seckinger, Anja; Jauch, Anna; Hillengass, Jens; Raab, Marc S; Schurich, Baerbel; Munder, Markus; Schmidt-Wolf, Ingo G H; Gerecke, Christian; Lindemann, Hans-Walter; Zeis, Matthias; Weisel, Katja; Dürig, Jan; Goldschmidt, Hartmut
    Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma : an interim analysis from the prospective GMMG-MM5 trial
    In: Haematologica / The Hematology Journal , Jg. 100 2015, Nr. 7, S. 964 – 969
    DOI (Open Access)
  • Wagner, Bettina; Nardi, FabiolaDaS; Schramm, Sabine; Kraemer, Thomas; Bade-Doeding, Christina; Dürig, Jan; Horn, Peter A.; Dührsen, Ulrich; Nueckel, Holger; Rebmann, Vera
    Increases levels of soluble HLA-E are associated with advanced disease stage and early treatment requirement in chronic lymphoytic leukemia
    In: Tissue Antigens , Jg. 84 2014, Nr. 1, S. 139 – 139
  • Gorgens, A.; Ludwig, A. K.; Mollmann, M.; Krawczyk, Adalbert; Dürig, Jan; Hanenberg, H.; Horn, Peter; Giebel, Bernd
    Multipotent hematopoietic progenitors divide asymmetrically to create progenitors of the lymphomyeloid and erythromyeloid lineages
    In: Stem Cell Reports , Jg. 3 2014, Nr. 6, S. 1058 – 1072
    DOI (Open Access)
  • Langerbeins, Petra; Busch, Raymonde; Anheier, Nadine; Dürig, Jan; Bergmann, Manuela; Goebeler, Maria-Elisabeth; Hurtz, Hans-Jürgen; Stauch, Martina B; Stilgenbauer, Stephan; Döhner, Hartmut; Fink, Anna-Maria; Cramer, Paula; Fischer, Kirsten; Wendtner, Clemens-Martin; Hallek, Michael; Eichhorst, Barbara
    Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation
    In: American Journal of Hematology , Jg. 89 2014, Nr. 12, S. E239 – 43
    DOI (Open Access)
  • Dührsen, Ulrich; Hüttmann, Andreas; Mueller, Stefan; Hertenstein, Bernd; Kotzerke, Joerg; Mesters, Rolf; Franzius, Christiane; Kroschinsky, Frank; Weckesser, Matthias; Franzke, Anke; Bengel, Frank; Dürig, Jan; Matschke, Johannes; Pöppel, Thorsten; Rekowski, Jan; Ose, Claudia; Brinkmann, Marcus; LaRosee, Paul; Freesmeyer, Martin; Hertel, Andreas; Hoeffkes, Heinz-Gert; Behringer, Dirk; Prange-Krex, Gabriele; Wilop, Stefan; Krohn, Thomas; Fricke, Eva; Griesshammer, Martin; Giagounidis, Aristotele; Raghavachar, Aruna; Maschmeyer, Georg; Brink, Ingo; Brecht, Arne; Haberkorn, Uwe; Gaska, Tobias; Klapper, Wolfram; Hoelzer, Dieter; Jöckel, Karl-Heinz; Scherag, Andre; Bockisch, Andreas
    Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)
    In: Blood , Jg. 124 2014, Nr. 21, S. 391
    DOI
  • Bergmann, Anke K; Schneppenheim, Sina; Seifert, Marc; Betts, Matthew J; Haake, Andrea; Lopez, Cristina; Maria Murga Penas, Eva; Vater, Inga; Jayne, Sandrine; Dyer, Martin J S; Schrappe, Martin; Dührsen, Ulrich; Ammerpohl, Ole; Russell, Robert B; Küppers, Ralf; Dürig, Jan; Siebert, Reiner
    Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia
    In: Genes, Chromosomes and Cancer , Jg. 53 2014, Nr. 4, S. 309 – 316
    DOI
  • Sellner, Leopold; Dietrich, Sascha; Lukas, Marina; Ho, Anthony D.; Blume, Carolin; Stolz, Tatjana; Hensel, Manfred; Rossi, Davide; Zenz, Thorsten; Zirlik, Katja; Glimm, Hanno; Oles, Malgorzata; Huber, Wolfgang; Seiffert, Martina; Slabicki, Mikolaj; Sill, Martin; Kalle, Christof von; Jauch, Anna; Hüllein, Jennifer; Ringshausen, Ingo; Merkel, Olaf; Dreger, Peter; Herling, Marco; Dürig, Jan; Oakes, Christopher C.
    Systematic mapping of drug sensitivity in hematological malignancies identifies vulnerability of chronic lymphocytic leukemia with mutant p53
    In: Cancer Research , Jg. 74 2014, Nr. 19 Suppl., S. 5557
    DOI
  • Seckinger, A.; Meissner, T.; Bertsch, U.; Salwender, H.; Dürig, Jan; Hanel, M.; Blau, I.; Scheid, C.; Weisel, K.; Klein, B.; Goldschmidt, H.; Hose, D.
    Bone turnover in multiple myeloma : Impact of bortezomib-based induction therapy, high-dose melphalan, and lenalidomide consolidation on osteoblast and osteoclast function within the GMMG-MM5 trial
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 38 – 38
  • Fedorchenko, Oleg; Stiefelhagen, Marius; Peer-Zada, Abdul A; Barthel, Romy; Mayer, Petra; Eckei, Laura; Breuer, Alexandra; Crispatzu, Giuliano; Rosen, Natascha; Landwehr, Thomas; Lilienthal, Nils; Möllmann, Michael; Montesinos-Rongen, Manuel; Heukamp, Lukas; Dürig, Jan; Hallek, Michael; Fingerle-Rowson, Günter; Herling, Marco
    CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia
    In: Blood , Jg. 121 2013, Nr. 20, S. 4126 – 4136
    DOI
  • Dürig, Jan
    CLL associated immunodeficiency
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 1 – 1
  • Goethert, JoachimRud; Eisele, Lewin; Klein-Hitpaß, Ludger; Weber, Stefanie; Zesewitz, Marie-Loui; Sellmann, Ludger; Röth, Alexander; Pircher, Hanspeter; Dührsen, Ulrich; Dürig, Jan
    Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1(+) effector memory phenotype
    In: Cancer Immunology, Immunotherapy , Jg. 62 2013, Nr. 11, S. 1697 – 1709
    DOI
  • Hose, D.; Seckinger, A.; Meissner, T.; Bertsch, U.; Salwender, H.; Dürig, Jan; Hanel, M.; Blau, I.; Scheid, C.; Weisel, K.; Klein, B.; Goldschmidt, H.
    Gene expression profiling and its arrival in clinical routine
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 170 – 170
  • Dürig, Jan
    Indolent T-cell lymphomas (T-LGL and others)
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 87 – 87
  • Khandanpour, Cyrus; Dürig, Jan; Dührsen, Ulrich
    Leukämien : Modellkrankheiten für die Entstehung und Behandlung von Krebs
    In: Unikate: Berichte aus Forschung und Lehre 2013, Nr. 44: Medizin : 50 Jahre Universitätsklinikum Essen, S. 114 – 125
    DOI, Online Volltext (Open Access)
  • Johansson, Patricia; Klein-Hitpaß, Ludger; Scholtysik, R.; Seifert, Marc; Jäger, Ursula; Tschurtschenthaler, G.; Dührsen, Ulrich; Küppers, Ralf; Dürig, Jan
    Next generation transcriptome sequencing confirms the presence of somatic STAT3 mutations and identifies novel TNFAIP3 mutations in T Large Granular Lymphocytic Leukemia (T-LGL)
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 196
  • Gobel, M.; Mollmann, M.; Gorgens, A.; Huttmann, A.; Dührsen, Ulrich; Giebel, Bernd; Unger, A.; Choidas, A.; Dürig, Jan
    Preclinical testing of a novel Axl-kinase inhibitor in Chronic Lymphocytic Leukemia
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 172 – 172
  • Eisele, Lewin; Dürig, Jan; Bröcker-Preuß, Martina; Dührsen, Ulrich; Bokhof, Beate; Erbel, Raimund; Moebus, Susanne; Jöckel, Karl-Heinz
    Prevalence and incidence of anemia in the German Heinz Nixdorf Recall Study
    In: Annals of Hematology , Jg. 92 2013, Nr. 6, S. 731 – 737
    DOI
  • Göbel, Maria; Eisele, Lewin; Möllmann, Michael; Hüttmann, Andreas; Johansson, Patricia; Scholtysik, Rene; Bergmann, Manuela; Busch, Raymonde; Döhner, Hartmut; Hallek, Michael; Seiler, Till; Stilgenbauer, Stephan; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan
    Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia
    In: PLoS ONE , Jg. 23 2013, Nr. 8, S. e72107
    DOI (Open Access)
  • Lutzny, Gloria; Kocher, Thomas; Schmidt-Supprian, Marc; Rudelius, Martina; Klein-Hitpaß, Ludger; Finch, Andrew J; Dürig, Jan; Wagner, Michaela; Haferlach, Claudia; Kohlmann, Alexander; Schnittger, Susanne; Seifert, Marc; Wanninger, Stefan; Zaborsky, Nadja; Oostendorp, Robert; Ruland, Jürgen; Leitges, Michael; Kuhnt, Toni; Schäfer, Yvonne; Lampl, Benedikt; Peschel, Christian; Egle, Alexander; Ringshausen, Ingo
    Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo
    In: Cancer Cell , Jg. 23 2013, Nr. 1, S. 77 – 92
    DOI (Open Access)
  • Görgens, André; Radtke, Stefan; Möllmann, Michael; Cross, Michael; Dürig, Jan; Horn, Peter; Giebel, Bernd
    Revision of the Human Hematopoietic Tree: Granulocyte Subtypes Derive from Distinct Hematopoietic Lineages
    In: Cell Reports , Jg. 3 2013, Nr. 5, S. 1539 – 1552
    DOI
  • Rost, S.; Necke, M.; Weber, S.; Mollmann, M.; Gobel, M.; Opalka, Bertram; Dührsen, Ulrich; Dürig, Jan; Gothert, J. R.
    Abundance of a NOTCH1 mutated clone affects clinical outcome of patients with chronic lymphocytic leukemia
    In: Onkologie , Jg. 35 2012, Nr. Suppl. 6, S. 97 – 97
  • Oppliger Leibundgut, Elisabeth; Rogenmoser-Dissler, Daniela; de Beer, Dirk; Porret, Naomi A.; Zibellini, Silvia; Dürig, Jan; Röth, Alexander; Klingbiel, Dirk; Baerlocher, Gabriela M.
    CLLU1 expression distinguishes chronic lymphocytic leukemia from other mature B-cell neoplasms
    In: Leukemia Research , Jg. 36 2012, Nr. 9, S. 1204 – 1207
    DOI
  • Seifert, Marc; Sellmann, Ludger; Bloehdorn, Johannes; Wein, Frederik; Stilgenbauer, Stephan; Dürig, Jan; Küppers, Ralf
    Cellular origin and pathophysiology of chronic lymphocytic leukemia
    In: Journal of Experimental Medicine (JEM) , Jg. 209 2012, Nr. 12, S. 2183 – 2198
    DOI (Open Access)
  • Johansson, Patricia; Klein-Hitpaß, Ludger; Scholtysik, René; Seifert, Marc; Jäger, Ulrich; Tschurtschenthaler, Gertraud; Dührsen, Ulrich; Küppers, Ralf; Dürig, Jan
    Combined SNP Microarray Based Genomic Mapping and Next Generation Transcriptome Sequencing Confirms the Presence of Somatic STAT3 Mutations and Identifies Novel Chromosomal Imbalances and Candidate Genes in T Large Granular Lymphocytic Leukemia (T-LGL)
    In: Blood , Jg. 120 2012, Nr. 21, S. 3512
    DOI
  • Hanoun, Maher; Eisele, Lewin; Suzuki, Masako; Greally, John M.; Hüttmann, Andreas; Aydin, Semra; Scholtysik, René; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan
    Epigenetic Silencing of the Circadian Clock Gene CRY1 is Associated with an Indolent Clinical Course in Chronic Lymphocytic Leukemia
    In: PLoS ONE , Jg. 7 2012, Nr. 12, S. e34347
    DOI (Open Access)
  • Faure, C.; Eisele, Lewin; Bergmann, M.; Busch, R.; Stilgenbauer, S.; Dührsen, Ulrich; Dürig, Jan; Deutsch CLL Studiengrp DCLLSG
    Evaluation of free light-chain abnormalities as prognostic marker in Binet A stage chronic lymphocytic leukemia
    In: Onkologie , Jg. 35 2012, Nr. Suppl. 6, S. 99 – 99
  • Görgens, A.; Radtke, Stefan; Mollmann, M.; Dürig, Jan; Horn, Peter; Giebel, Bernd
    Functional analyses of human hemtopoietic CD133(+)CD34(+) and CD133(LOW/-)CD34(+) cells challenge the existence of human common myeloid progenitor cells
    In: Experimental Hematology , Jg. 40 2012, Nr. 8, Suppl. 1, S. 124
  • Görgens, Andre; Beckmann, Julia; Ludwig, Anna-Kristin; Möllmann, Michael; Dürig, Jan; Horn, Peter; Rajendran, Lawrence; Giebel, Bernd
    Lipid raft redistribution and morphological cell polarization are separable processes providing a basis for hematopoietic stem and progenitor cell migration
    In: The International Journal of Biochemistry & Cell Biology , Jg. 44 2012, Nr. 7, S. 1121 – 1132
    DOI
  • Goergens, Andre; Goebel, Maria; Mollmann, Michael; Ludwig, Anna-Kristin; Dührsen, Ulrich; Horn, Peter; Dürig, Jan; Giebel, Bernd
    Molecular and morphological cell polarizationis required for human hematopoietic stem and progenitor cell migration and homing
    In: Experimental Hematology , Jg. 40 2012, Nr. 8, Suppl. 1, S. S106 – S107
  • Goebel, Maria; Möllmann, Michael; Gorgens, A.; Dührsen, Ulrich; Huttmann, A.; Giebel, Bernd; Unger, A.; Choidas, A.; Dürig, Jan
    Preclinical Testing of a Novel Axl-Kinase Inhibitor in Chronic Lymphocytic Leukemia
    In: Blood , Jg. 120 2012, Nr. 21
  • Eisele, Lewin; Dürig, Jan; Hüttmann, Andreas; Dührsen, Ulrich; Assert, Roland; Bokhof, B.; Erbel, Raimund; Mann, K.; Jöckel, Karl-Heinz; Moebus, Susanne; on behalf of the Heinz Nixdorf Recall Study Investigative Group
    Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany
    In: Annals of Hematology , Jg. 91 2012, Nr. 2, S. 243 – 248
    DOI
  • Gobel, M.; Eisele, Lewin; Hüttmann, Andreas; Bergmann, M.; Busch, R.; Stilgenbauer, S.; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan
    Progranulin plasma concentration is a novel independent prognostic marker in chronic lymphocytic leukemia
    In: Onkologie , Jg. 35 2012, Nr. Suppl. 6, S. 100
  • Lutzny, G.; Kocher, T.; Rudelius, M.; Schmidt-Supprian, M.; Klein-Hitpaß, Ludger; Dürig, Jan; Oostendorp, RAJ; Peschel, C.; Egle, A.; Ringshausen, I.
    Protein Kinase C-beta Dependent Activation of NF-kappa B in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B-Cells in Vivo
    In: Blood , Jg. 120 2012, Nr. 21, S. 314
  • Johansson, Patricia; Eisele, Lewin; Wymer, Leonie; Hollenbeck, Anita; Kahraman, Alisan; Hilgard, Gudrun; Dührsen, Ulrich; Bröcker-Preuß, Martina; Assert, Roland; Gerken, Guido; Schlaak, Jörg Friedrich; Roß, Rudolf Stefan; Dürig, Jan
    Serum immunoglobulin alterations in patients with chronic hepatitis C
    In: Onkologie , Jg. 35 2012, Nr. Suppl. 6, S. 142 – 143
  • Gobel, M.; Mollmann, M.; Gorgens, A.; Giebel, Bernd; Dührsen, Ulrich; Dürig, Jan
    Toll-like receptor 9 agonists induce polarization and migration of chronic lymphocytic leukemia cells
    In: Onkologie , Jg. 35 2012, Nr. Suppl. 6, S. 106
  • Weißhardt, Philipp; Trarbach, Tanja; Dürig, Jan; Paul, Andreas; Reis, Henning; Tilki, Derya; Miroschnik, Inna; Ergün, Süleyman; Klein, Diana
    Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab
    In: Histochemistry and Cell Biology , Jg. 137 2012, Nr. 3, S. 391 – 401
    DOI
  • Sellmann, Ludger; Carpinteiro, Alexander; Nückel, Holger; Scholtysik, René; Siemer, Dörte; Klein-Hipass, Ludger; Kube, Dieter; Dürig, Jan; Dührsen, Ulrich; Stanelle, Jens; Küppers, Ralf
    p53 protein expression in chronic lymphocytic leukemia
    In: Leukemia and Lymphoma , Jg. 53 2012, Nr. 7, S. 1282 – 1288
    DOI
  • Switala, M.; Nückel, Holger; Ochsenfarth, C.; Dürig, Jan; Dührsen, Ulrich; Horn, Peter; Rebmann, Vera
    Association of soluble MICA levels to the MICA-129 polymorphism and treatment free survival in chronic lymphocytic leukaemia patients
    In: Tissue Antigens , Jg. 77 2011, Nr. 5, S. 393 – 393
  • Wierda, William G.; Kipps, Thomas J.; Dürig, Jan; Griskevicius, Laimonas; Stilgenbauer, Stephan; Mayer, Jiří; Smolej, Lukáš; Hess, Georg; Griniute, Rasa; Hernandez-Ilizaliturri, Francisco J.; Padmanabhan, Swaminathan; Gorczyca, Michele; Chang, Chai-Ni; Chan, Geoffrey; Gupta, Ira; Nielsen, Tina G.; Russell, Charlotte A.; Chang, C.-N.
    Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia
    In: Blood , Jg. 117 2011, Nr. 24, S. 6450 – 6458
    DOI
  • Aydin, Semra; Grabellus, Florian; Eisele, Lewin; Möllmann, Michael; Hanoun, Maher; Ebeling, Peter; Moritz, Thomas; Nückel, Holger; Sak, Ali; Göthert, Joachim Rudolf; Dührsen, Ulrich; Dürig, Jan
    Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model
    In: European Journal of Haematology , Jg. 87 2011, Nr. 1, S. 10 – 19
    DOI
  • Eisele, Lewin; Dürig, Jan; Bokhof, B.; Huttmann, A.; Dührsen, Ulrich; Assert, Roland; Erbel, R.; Jockel, K. H.; Moebus, S.
    Monoclonal gammopathy of undetermined significance and solid tumor development in the Heinz Nixdorf Recall Study
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,
    In: Onkologie , Jg. 34 2011, Nr. Suppl. 6, S. 243
    DOI
  • May, T.; Schucht, R.; Zauers, J.; Dürig, Jan; Horn, Peter; Rebmann, Vera; Dührsen, Ulrich; Göthert, Joachim Rudolf; Opalka, Bertram
    Novel human bone marrow stroma cell lines from a normal donor and leukemia and lymphoma patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,
    In: Onkologie , Jg. 34 2011, Nr. Suppl. 6, S. 260
    DOI
  • Sellmann, Ludger; Röth, Alexander; Baerlocher, Gabriela M.; Küppers, Ralf; Siemer, Dörte; Seifert, Marc; Dürig, Jan; Dührsen, Ulrich; Nückel, Holger; Opalka, Bertram; Bartels, Marius; de Beer, Dirk
    Telomeres and prognosis in patients with chronic lymphocytic leukaemia
    In: International Journal of Hematology , Jg. 93 2011, Nr. 1, S. 74 – 82
    DOI
  • Dürig, Jan; Dührsen, Ulrich; Klein-Hitpaß, Ludger; Worm, J.; Rode Hansen, J.B.; Wissenbach, M.
    The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia
    In: Leukemia , Jg. 25 2011, Nr. 4, S. 638 – 647
    DOI
  • Johansson, Patricia; Maldonado de Dechene, E.; Eisele, Lewin; Kieruzel, Sabrina; Horn, Peter; Schmücker, U.; Vetter, Irina; Dührsen, Ulrich; Gerken, Guido; Dürig, Jan; Schlaak, Jörg Friedrich
    705 Increased prevalence of monoclonal b lymphocytosis in patients with chronic Hepatitis C
    In: Journal of Hepatology , Jg. 52 2010, Nr. Suppl. 1, S. S274
    DOI
  • Wierda, W. G.; Kipps, T. J.; Dürig, Jan; Griskevicius, L.; Stilgenbauer, S.; Mayer, J.; Gorczyca, M.; Andersen, M.; Nielsen, T.; Russell, C. A.
    Chemoimmunotherapy with ofatumumab, fludarabine, and cyclophosphamide (O-FC) in previously untreated patients with chronic lymphocytic leukemia (CLL)
    In: Journal of Clinical Oncology (JCO) , Jg. 28 2010, Nr. Suppl. 15, S. 6520
    DOI
  • Handrick, René; Ontikatze, Teona; Bauer, Kerstin-Daniela; Freier, Florian; Rübel, Amelie; Dürig, Jan; Belka, Claus; Jendrossek, Verena
    Dihydroartemisinin induces apoptosis by a bak-dependent intrinsic pathway
    In: Molecular Cancer Therapeutics , Jg. 9 2010, Nr. 9, S. 2497 – 2510
    DOI (Open Access)
  • Sellmann, Ludger; Scholtysik, Rene; Kreuz, Markus; Cyrull, Sandra; Tiacci, Enrico; Stanelle, Jens; Carpinteiro, Alexander; Nückel, Holger; Boes, Tanja; Gesk, Stefan; Siebert, Reiner; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan; Küppers, Ralf
    Gene dosage effects in chronic lymphocytic leukemia
    In: Cancer Genetics and Cytogenetics , Jg. 203 2010, Nr. 2, S. 149 – 160
    DOI
  • Wierda, William G.; Kipps, Thomas J.; Dürig, Jan; Griskevicius, Laimonas; Stilgenbauer, Stephan; Mayer, Jiri; Smolej, Lukas; Hess, Georg; Griniute, Rasa; Hernandez-Ilizaliturri, Francisco J.; Padmanabhan, Swaminathan; Gorczyca, Michele; Gupta, Ira; Nielsen, Tina G.; Russell, Charlotte A.
    Ofatumumab Combined With Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients With Previously Untreated Chronic Lymphocytic Leukemia : Results From a Randomized, Multicenter, International, Two-Dose, Parallel-Group Phase II Trial
    In: Clinical Lymphoma, Myeloma & Leukemia , Jg. 10 2010, Nr. 3, S. E33 – E34
    DOI
  • Johansson, Patricia; Eisele, Lewin; Klein-Hitpaß, Ludger; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan; Nückel, Holger
    Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia
    In: Leukemia Research , Jg. 34 2010, Nr. 7, S. 892 – 898
    DOI
  • Eisele, Lewin; Dürig, Jan; Hüttmann, Andreas; Dührsen, U.; Führer, A.; Kieruzel, S.; Assert, Roland; Bokhof, B.; Erbel, Raimund; Mann, Klaus; Jöckel, Karl-Heinz; Moebus, Susanne
    Prevalence of monoclonal gammopathy of undetermindes significance in a densley populated, highly industrialized area in Germany
    15th Congress of the European Hematology Association, Spain, Barcelona, June 10–13, 2010,
    In: Haematologica, the hematology journal , Jg. 95 2010, Nr. Suppl. 2 , S. 394, 0949
  • Dührsen, Ulrich; Hüttmann, Andreas; Dürig, Jan
    Prognostic Significance of Molecular Remission in Follicular Lymphoma
    In: Journal of Clinical Oncology (JCO) , Jg. 28 2010, Nr. 30, S. e613
    DOI
  • Aydin, S.; Grabellus, Florian; Ebeling, Peter; Mollmann, M.; Lewin, E.; Nükel, H.; Dürig, Jan
    The impact of CD38 in the CLL NOD/SCID xenograft model
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6, S. 200 – 201
  • Nückel, Holger; Switala, Magdalena; Sellmann, Ludger; Horn, Peter; Dürig, Jan; Dührsen, Ulrich; Küppers, Ralf; Grosse-Wilde, Hans; Rebmann, Vera
    The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia
    In: Leukemia , Jg. 24 2010, Nr. 6, S. 1152 – 1159
    DOI
  • Zenz, Thorsten; Benner, Axel; Dührsen, Ulrich; Dürig, Jan; Döhner, Hartmut; Siffert, Winfried; Stilgenbauer, Stephan; Nückel, Holger
    BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia
    In: Leukemia and Lymphoma , Jg. 50 2009, Nr. 11, S. 1837 – 1842
  • Wilde, Benjamin; Dolff, Sebastian; Cai, Xin; Specker, Christof; Becker, Jan; Tötsch, Martin; Costabel, Ulrich; Dürig, Jan; Kribben, Andreas; Tervaert, Jan Willem Cohen; Schmid, Kurt Werner; Witzke, Oliver
    CD4⁺CD25⁺ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis
    In: Nephrology Dialysis Transplantation (NDT) , Jg. 24 2009, Nr. 1, S. 161 – 171
    DOI (Open Access)
  • Eisele, Lewin; Prinz, Robert; Klein-Hitpaß, Ludger; Nückel, Holger; Lowinksi, Kerstin; Thomale, Jürgen; Möller, Lars; Dührsen, Ulrich; Dürig, Jan
    Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia
    In: European Journal of Haematology , Jg. 83 2009, Nr. 4, S. 320 – 327
    DOI
  • Eisele, Lewin; Haddad, Tareq; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan
    Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia
    In: Leukemia Research , Jg. 33 2009, Nr. 6, S. 775 – 778
    DOI
  • Nückel, Holger; Collins, Christa H.; Sellmann, Ludger; Dürig, Jan; Siffert, Winfried; Dührsen, Ulrich
    FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia
    In: European Journal of Haematology , Jg. 83 2009, Nr. 6, S. 541 – 549
    DOI
  • Bug, Stefanie; Dürig, Jan; Oyen, Florian; Klein-Hitpaß, Ludger; Martin-Subero, Jose; Harder, Lana; Baudis, Michael; Arnold, Norbert; Kordes, Uwe; Dührsen, Ulrich; Schneppenheim, Reinhard; Siebert, Reiner
    Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A–TCRAD juxtaposition
    In: Cancer Genetics and Cytogenetics , Jg. 192 2009, Nr. 1, S. 44 – 47
    DOI
  • Edelmann, J.; Klein-Hitpaß, Ludger; Führer, A.; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan
    Bone marrow fibroblasts induce expression of PI3K/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells
    In: Leukemia Research , Jg. 32 2008, Nr. 10, S. 1565 – 1572
    DOI
  • Dürig, Jan; Ebeling, Peter; Grabellus, Florian; Sorg, Ursula R.; Möllmann, Michael; Schütt, Philipp; Göthert, Joachim Rudolf; Sellmann, Ludger; Seeber, Siegfried; Flaßhove, Michael; Dührsen, Ulrich; Moritz, Thomas
    A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease
    In: Cancer Research , Jg. 67 2007, Nr. 18, S. 8653 – 8661
    DOI
  • Nückel, Holger; Frey, Ulrich; Bau, Maja; Sellmann, Ludger; Stanelle, Jens; Dürig, Jan; Jöckel, Karl-Heinz; Dührsen, Ulrich; Siffert, Winfried
    Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia
    In: Blood , Jg. 109 2007, Nr. 1, S. 290 – 297
    DOI
  • Dürig, Jan; Bug, S.; Klein-Hitpaß, Ludger; Boes, Tanja; Jöns, T.; Harder, L.; Baudis, M.; Dührsen, Ulrich; Siebert, Reiner
    Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32)
    In: Leukemia , Jg. 21 2007, Nr. 10, S. 2153 – 2163
    DOI
  • Röth, Alexander; Dürig, Jan; Himmelreich, H.; Bug, S.; Siebert, Reiner; Dührsen, Ulrich; Lansdorp, M.; Baerlocher, Gabriele
    Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia
    In: Leukemia , Jg. 21 2007, Nr. 12, S. 2456 – 2462
    DOI
  • Sellmann, Ludger; Gesk, Stefan; Walter, Christoph; Ritgen, Matthias; Harder, Lana; Schroers, Roland; Siemer, Dörte; Nückel, Holger; Dührsen, Ulrich; Siebert, Reiner; Dürig, Jan; Küppers, Ralf
    Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia
    In: British Journal of Haematology , Jg. 138 2007, Nr. 2, S. 217 – 220
    DOI
  • Broemel, F.; Kruse, E.; Neuhäuser, Markus; Dürig, Jan; Jöckel, Karl-Heinz
    A correction for expression value dependencies in Affymetrix
    In: Online Journal of Bioinformatics (OJB) , Jg. 7 2006, Nr. 1, S. 1 – 14
  • Nückel, Holger; Frey, Ulrich; Sellmann, Ludger; Bau, M.; Dürig, Jan; Dührsen, Ulrich; Siffert, Winfried
    Bax gene G(-248)A promoter polymorphism and chronic lymphocytic leukemia: lack of association with incidence, disease stage and progression-free survival
    In: Leukemia , Jg. 20 2006, Nr. 4, S. 724
    DOI
  • Hüttmann, Andreas; Klein-Hitpaß, Ludger; Thomale, Jürgen; Deenen, R.; Nückel, Holger; Ebeling, Peter; Führer, A.; Edelmann, J.; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan
    Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status
    In: Leukemia , Jg. 20 2006, Nr. 10, S. 1774 – 1782
    DOI
  • Nückel, Holger; Hüttmann, Andreas; Klein-Hitpaß, Ludger; Schroers, Roland; Führer, Anja; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan
    Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia
    In: Leukemia & Lymphoma , Jg. 47 2006, Nr. 6, S. 1053 – 1061
    DOI
  • Frey, Ulrich; Nückel, Holger; Sellmann, Ludger; Siemer, Dörte; Küppers, Ralf; Siemer, Dörte; Küppers, Ralf; Dürig, Jan; Dührsen, Ulrich; Siffert, Winfried
    The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia
    In: Clinical Cancer Research , Jg. 12 2006, Nr. 19, S. 5686 – 5692
    DOI
  • Schroers, R.; Griesinger, F.; Trümper, L.; Haase, D.; Kulle, B.; Klein-Hitpaß, Ludger; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan
    Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia
    In: Leukemia , Jg. 19 2005, Nr. 5, S. 750 – 758
    DOI
  • Nückel, Holger; Rebmann, Vera; Dürig, Jan; Dührsen, Ulrich; Grosse-Wilde, Hans
    HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia
    In: Blood , Jg. 105 2005, Nr. 4, S. 1694 – 1698
    DOI
  • Schroers, Roland; Pukrop, Tobias; Dürig, Jan; Haase, Detlef; Dührsen, Ulrich; Trümper, Lorenz; Griesinger, Frank
    B-cell chronic lymphocytic leukemia with aberrant CD8 expression : genetic and immunophenotypic analysis of prognostic factors
    In: Leukemia & Lymphoma , Jg. 45 2004, Nr. 8, S. 1677 – 1681
    DOI
  • Novotny, Jürgen; Rosenthal, C.; Dürig, Jan; Beelen, Dietrich
    Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation
    In: European Journal of Haematology , Jg. 73 2004, Nr. 1, S. 1 – 9
    DOI
  • Nückel, Holger; Frey, Ulrich; Dürig, Jan; Dührsen, Ulrich; Siffert, Winfried
    Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia
    In: Leukemia , Jg. 18 2004, Nr. 11, S. 1816 – 1823
    DOI
  • Deaglio, Silvia; Capobianco, Andrea; Bergui, Luciana; Dürig, Jan; Morabito, Fortunato; Dührsen, Ulrich; Malavasi, Fabio
    CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells
    In: Blood , Jg. 102 2003, Nr. 6, S. 2146 – 2155
    DOI
  • Dürig, Jan; Nückel, Holger; Hüttmann, Andreas; Kruse, Elisabeth; Hölter, Tanja; Halfmeyer, Katja; Führer, Anja; Rudolph, Roland; Kalhori, Nasa; Nusch, Arnd; Deaglio, Silvia; Malavasi, Fabio; Möröy, Tarik; Klein-Hitpaß, Ludger; Dührsen, Ulrich
    Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia
    In: Blood , Jg. 101 2003, Nr. 7, S. 2748 – 2755
    DOI
  • Nückel, Holger; Dürig, Jan; Dührsen, Ulrich
    Salvage chemotherapy according to the ASHAP protocol : a single-center study of 24 patients with relapsed or refractory aggressive non-Hodgkin's lymphomas
    In: Annals of Hematology , Jg. 82 2003, Nr. 8, S. 481 – 486
    DOI
  • Nückel, Holger; Frey, Ulrich; Dürig, Jan; Dührsen, Ulrich; Siffert, Winfried; Aral, Nese
    The CC genotype of the C825T polymorphism of the G protein beta3 gene (GNB3) is associated with a high relapse rate in patients with chronic lymphocytic leukaemia
    In: Leukemia & Lymphoma , Jg. 44 2003, Nr. 10, S. 1739 – 1743
    DOI
  • Dürig, Jan; Nückel, Holger; Cremer, M.; Führer, A.; Halfmeyer, K.; Fandrey, Joachim; Möröy, Tarik; Klein-Hitpaß, Ludger; Dührsen, Ulrich
    ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia
    In: Leukemia , Jg. 17 2003, Nr. 12, S. 2426 – 2434
    DOI
  • Dürig, Jan; Naschar, M.; Schmücker, U.; Renzing-Köhler, K.; Hölter, T.; Hüttmann, Andreas; Dührsen, Ulrich
    CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia
    In: Leukemia , Jg. 16 2002, Nr. 1, S. 30 – 35
    DOI
  • Dürig, Jan; Schmücker, U.; Dührsen, Ulrich
    Differential expression of chemokine receptors in B cell malignancies
    In: Leukemia , Jg. 15 2001, Nr. 5, S. 752 – 756
  • Dührsen, Ulrich; Martinez, Tanja; Vohwinkel, G.; Ergün, Süleyman; Sun, Li; Dürig, Jan; Hossfeld, Dieter Kurt; Fiedler, W.
    Effects of vascular endothelial and platelet-derived growth factor receptor inhibitors on long-term cultures from normal human bone marrow
    In: Growth Factors , Jg. 19 2001, Nr. 1, S. 1 – 17
    DOI
  • Dürig, Jan; Rosenthal, Christoph; Elmaagacli, Ahmet Hayri; Heyworth, C.; Halfmeyer, Katja; Kasper, C.; Novotny, Jürgen; Dührsen, Ulrich
    Biological effects of stroma-derived factor-1 alpha on normal and CML CD34+ haemopoietic cells
    In: Leukemia , Jg. 14 2000, Nr. 9, S. 1652 – 1660
  • Dürig, Jan; Giese, Armin; Schulz-Schaeffer, Walter; Rosenthal, Christoph; Schmücker, Ute; Bieschke, Jan; Dührsen, Ulrich; Kretzschmar, Hans A.
    Differential constitutive and activation-dependent expression of prion protein in human peripheral blood leucocytes
    In: British Journal of Haematology , Jg. 108 2000, Nr. 3, S. 488 – 495
    DOI
  • Dürig, Jan; Rosenthal, Christoph; Halfmeyer, Katja; Wiemann, Martin; Novotny, Jürgen; Bingmann, Dieter; Dührsen, Ulrich; Schirrmacher, Karin
    Intercellular communication between bone marrow stromal cells and CD34+ haematopoietic progenitor cells is mediated by connexin 43-type gap junctions
    In: British Journal of Haematology , Jg. 111 2000, Nr. 2, S. 416 – 425
    DOI

    • Abstracts

  • Denker, Sophy; Bittner, Aitomi; Kase, Julia; Frick, Mareike; Hoffmann, Jörg; Trenker, Corinna; Keller, Ulrich; Bogner, Christian; Hüttmann, Andreas; Dürig, Jan; Janz, Martin; Mathas, Stephan; Marks, Reinhard; Krohn, Ulrike; Na, Il-Kang; Richter-Pechanska, Paulina; Bhattacharya, Animesh; Gebauer, Bernhard; Savic, Lynn; Hübner, Norbert; Akalin, Altuna; Eils, Roland; Bullinger, Lars; Schmitt, Clemens
    Targeted Treatment Additions Ibrutinib + Bortezomib + R-CHOP for Higher-Risk DLBCL : Efficacy, Feasibility and Molecular Signatures for Future Treatment Decisions
    The 66th ASH Annual Meeting, December 7-10, 2024, San Diego, USA,
    In: Blood , Jg. 144 2024, Nr. Supplement 1, S. 6188
    DOI (Open Access)
  • Fürstenau, Moritz; Ritgen, Matthias; Robrecht, Sandra; Von Tresckow, Julia; Zhang, Can; Schilhabel, Anke; Gregor, Michael; Thornton, Patrick; Staber, Philipp Bernhard; Tadmor, Tamar; Lindström, Vesa; Juliusson, Gunnar; Janssens, Ann; Levin, Mark-David; Da Cunha-Bang, Caspar; Schneider, Christof; Goldschmidt, Neta; Vandenberghe, Elisabeth; Rossi, Davide; Benz, Rudolf A.; Heintel, Daniel; Poulsen, Christian Bjørn; Christiansen, Ilse; Frederiksen, Henrik; Enggaard, Lisbeth; Posthuma, Eduardus; Issa, Djamila; Visser, Hein; Bellido, Mar; Kutsch, Nadine; Dürig, Jan; Stehle, Alexander; Voehringer, Matthias C.; Böttcher, Sebastian; Schulte, Clemens; Simon, Florian; Fink, Anna-Maria; Fischer, Kirsten; Holmes, Emily; Kreuzer, Karl-Anton; Brüggemann, Monika; Tausch, Eugen; Stilgenbauer, Stephan; Hallek, Michael; Kater, Arnon P.; Niemann, Carsten Utoft; Eichhorst, Barbara F.
    First-Line Venetoclax Combinations in Fit Patients with CLL : 4-Year Follow-up and NGS-Based MRD Analysis from the Phase 3 GAIA/CLL13 Trial
    In: Blood , Jg. 142 2023, Nr. Supplement 1, S. 635 – 638
    DOI (Open Access)
  • Denker, S.; Bittner, A.; Frick, M.; Kase, J.; Hoffmann, J.; Trenker, C.; Keller, U.; Bogner, C.; Hüttmann, Andreas; Dürig, Jan; Janz, M.; Mathas, S.; Marks, R.; Krohn, U.; Na, I.; Bhattacharya, A.; Hübner, N.; Akalin, A.; Bullinger, L.; Schmitt, C.A.
    Ibrutinib + bortezomib + R‐CHOP for higher‐risk DLBCL : Feasibility, efficacy and molecular predictors
    In: Hematological Oncology , Jg. 41 2023, Nr. S2, 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023, S. 424 – 425
    DOI (Open Access)
  • Ton, Gigi Nu Hoang Quy; Kriegsmann, Katharina; Awwad, Mohamed H.S.; Benner, Axel; Bertsch, Uta; Besemer, Britta; Hänel, Mathias; Fenk, Roland; Schlenzka, Jana; Munder, Markus; Dürig, Jan; Blau, Igor Wolfgang; Huhn, Stefanie; Hose, Dirk; Jauch, Anna; Neubauer, Andreas; Weinhold, Niels; Scheid, Christof; Schroers, Roland; von Metzler, Ivana; Schieferdecker, Aneta; Thomalla, Jörg; Reimer, Peter; Mahlberg, Rolf; Graeven, Ullrich; Kremers, Stephan; Martens, Uwe; Kunz, Christian; Hensel, Manfred; Seidel-Glätzer, Andrea; Weisel, Katja; Salwender, Hans; Müller-Tidow, Carsten; Raab, Marc S.; Goldschmidt, Hartmut; Mai, Elias K.; Hundemer, Michael
    Immunological Subgroups Predicting Efficacy of Elotuzumab in Multiple Myeloma Patients : Insights from the GMMG-HD6 Clinical Trial
    65th Annual Meeting of the American-Society-of-Hematology (ASH): DEC 09-12, 2023; San Diego, USA,
    In: Blood , Jg. 142 2023, Nr. Suppl. 1, S. 1991 – 1991
    DOI (Open Access)
  • Huber, H.; Tausch, E.; Schneider, C.; von Tresckow, Julia; Dürig, Jan; Stilgenbauer, S.; et al.
    Treatment regimens in high-risk CLL
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment , Jg. 46 2023, Nr. Supplement 5: DGHO Abstracts, S. 19
    DOI (Open Access)
  • Huber, Henriette; Tausch, Eugen; Schneider, Christof; Edenhofer, Simone; von Tresckow, Julia; Robrecht, Sandra; Giza, Adam; Zhang, Can; Furstenau, Moritz; Dreger, Peter; Ritgen, Matthias; Illmer, Thomas; Illert, Anna Lena; Dürig, Jan; Böttcher, Sebastian; Niemann, Carsten Utoft; Kneba, Michael; Fink, Anna-Maria; Fischer, Kirsten; Döhner, Hartmut; Hallek, Michael; Eichhorst, Barbara; Stilgenbauer, Stephan
    Final Analysis of the Prospective Multicenter CLL2-Give Trial of Obinutuzumab (GA101, G), Ibrutinib (I), and Venetoclax (Ve) in Untreated Patients with CLL with 17p Deletion/TP53 Mutation
    64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,
    In: Blood , Jg. 140 2022, Nr. Supplement 1, S. 834 – 836
    DOI (Open Access)
  • Kersten, Marie José; Dreyling, Martin; Linton, Kim M.; Chitu, Dana; Tonino, Sanne; Kap, Marcel; Liu, Roberto D; Chamuleau, Martine E.D.; Visser, Hein P.J.; De Jongh, Eva; Marijt, Erik WAF; Leijs, Maria B.L.; Bilgin, Yavuz M.; Dürig, Jan; McKay, Pamela; Snijders, Tjeerd J.F.; Pettitt, Andrew; Minnema, Monique C.; Prange-Krex, Gabriele; Cuijpers, Maria; Böhmer, Lara H.; Tick, Lidwine W.; Florschütz, Axel; Silbermann, Matthijs; Fijnheer, Rob; Beeker, Aart; Tolboom, Nelleke; Mitea, Cristina; Arens, Anne IJ; Zwezerijnen, Gerben JC; Klapper, Wolfram; Coupland, Sarah E.; de Jong, Daphne; Doorduijn, Jeanette K.; Zijlstra, Josée M.
    Lenalidomide-Rituximab or Lenalidomide-Rituximab-Bendamustine in Patients with Relapsed/Refractory Follicular Lymphoma : Priimary Analysis of the Randomized Phase II HOVON110/Rebel Trial
    64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans,
    In: Blood , Jg. 140 2022, Nr. Supplement 1: 64th Annual Meeting, S. 2283 – 2285
    DOI (Open Access)
  • Goldschmidt, Hartmut; Mai, Elias K; Nievergall, Eva; Fenk, Roland; Bertsch, Uta; Tichy, Diana; Besemer, Britta; Dürig, Jan; Schroers, Roland; Metzler, Ivana v.; Haenel, Mathias; Mann, Christoph; Asemissen, Anne-Marie; Heilmeier, Bernhard; Huhn, Stefanie; Kriegsmann, Katharina; Weinhold, Niels; Luntz, Steffen P.; Holderried, Tobias A. W.; Trautmann-Grill, Karolin; Gezer, Deniz; Klaiber-Hakimi, Maika; Mueller, Martin; Khandanpour, Cyrus; Knauf, Wolfgang; Munder, Markus; Geer, Thomas; Riesenberg, Hendrik; Thomalla, Joerg; Hoffmann, Martin; Raab, Marc-Steffen; Salwender, Hans; Weisel, Katja
    Addition of Isatuximab to Lenalidomide, Bortezomib and Dexamethasone As Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma Patients : The Phase III GMMG-HD7 Trial
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood , Jg. 138 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 463 – 465
    DOI (Open Access)
  • Goldschmidt, Hartmut; Mai, Elias K; Bertsch, Uta; Besemer, Britta; Haenel, Mathias; Miah, Kaya; Fenk, Roland; Schlenzka, Jana; Munder, Markus; Dürig, Jan; Blau, Igor Wolfgang; Huhn, Stefanie; Hose, Dirk; Jauch, Anna; Kunz, Christina; Neubauer, Andreas; Scheid, Christof; Schroers, Roland; Metzler, Ivana v.; Schieferdecker, Aneta; Thomalla, Joerg; Reimer, Peter; Mahlberg, Rolf; Graeven, Ullrich; Kremers, Stephan; Martens, Uwe M.; Kunz, Christian; Hensel, Manfred; Seidel-Glaetzer, Andrea; Weisel, Katja; Raab, Marc-Steffen; Salwender, Hans
    Elotuzumab in Combination with Lenalidomide, Bortezomib, Dexamethasone and Autologous Transplantation for Newly-Diagnosed Multiple Myeloma : Results from the Randomized Phase III GMMG-HD6 Trial
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood , Jg. 138 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 486 – 488
    DOI (Open Access)
  • Hoffmann, C.; Mohr, Christopher; Johansson, Patricia; Dürig, Jan; Schmeling, C.; Bechrakis, N.; Eckstein, Anja; Manthey, A.; Pöttgen, Christoph; Gauler, Thomas; Guberina, N.; Müller, Andrea; Stuschke, Martin; Guberina, M.
    Long-term Follow-Up in Patients with Stage IAE Orbital Lymphoma and Radiotherapy with Photons : Monocentric Results
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 58 – S59
  • Mai, Elias K; Hielscher, Thomas; Bertsch, Uta; Salwender, Hans; Zweegman, Sonja; Munder, Markus; Pantani, Lucia; Brossart, Peter; Beksac, Meral; Blau, Igor Wolfgang; Raab, Marc-Steffen; Dürig, Jan; Giesen, Nicola; Besemer, Britta; Fenk, Roland; Reimer, Peter; van der Holt, Bronno; Haenel, Mathias; Metzler, Ivana v.; Graeven, Ullrich; Boccadoro, Mario; Scheid, Christof; Dimopoulos, Meletios A.; Weisel, Katja; Cavo, Michele; Sonneveld, Pieter; Goldschmidt, Hartmut
    Prediction of Early Death and Severe Infections during Novel Agent-Based Induction Therapy in Newly-Diagnosed Multiple Myeloma : An Intergroup Analysis from the German Speaking Myeloma Multicenter Group, the Dutch-Belgian Cooperative Trial Group for Hematology Oncology Foundation and the European Myeloma Network
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood , Jg. 138 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 3792 – 3795
    DOI (Open Access)
  • Mai, E. K.; Hielscher, T.; Bertsch, U.; Salwender, H. J.; Munder, M.; Brossart, P.; Blau, I. W.; Raab, M. S.; Dürig, Jan; Besemer, B.; Fenk, R.; Wattad, M.; Hänel, M.; Martin, H.; Graeven, U.; Scheid, Christoph; Weisel, K. C.; Goldschmidt, H.; German-speaking Myeloma Multicenter Group (GMMG)
    Severe infections and early death during novel agent-based induction therapy in newly-diagnosed, transplant-eligible multiple myeloma
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment , Jg. 44 2021, Nr. Supplement 2, S. 21
    DOI (Open Access)
  • Mai, Elias K.; Baertsch, Marc-A.; Hielscher, Thomas; Bertsch, Uta; Schlenzka, Jana; Salwender, Hans J.; Munder, Markus; Fuhrmann, Stephan; Dührsen, Ulrich; Brossart, Peter; Neben, Kai; Raab, Marc S.; Jauch, Anna; Seckinger, Anja; Hose, Dirk; Luntz, Steffen; Sonneveld, Pieter; Lokhorst, Henk; Martin, Hans; Lindemann, Hans-Walter; Blau, Igor Wolfgang; Scheid, Christof; Weisel, Katja; Haenel, Mathias; Dürig, Jan; Goldschmidt, Hartmut
    Comparison of bortezomib versus lenalidomide maintenance therapy in newly-diagnosed, transplant-eligible multiple myeloma : Results from the phase III GMMG-HD4 and -MM5 trials
    17th International Myeloma Workshop ; September 12-15, 2019, Boston, MA, USA,
    In: Clinical Lymphoma, Myeloma & Leukemia , Jg. 19 2019, Nr. 10, Suppl., S. e43
    DOI
  • Dimopoulos, Meletios A.; Weisel, Katja; Moreau, Philippe; Anderson, Larry D.; White, Darrell; San-Miguel, Jesus; Sonneveld, Pieter; Engelhardt, Monika; Jenner, Matthew; Corso, Alessandro; Dürig, Jan; Pavic, Michel; Salomo, Morten; Casalz, Eva; Jiang, Ruiyun; Srinivasan, Shankar; Nguyen, Tuong Vi; Bensmaine, Amine; Peluso, Teresa; Richardson, Paul G.
    Pomalidomide + Bortezomib + Dexamethasone After One Prior Line of Therapy in Bortezomib-Pretreated Multiple Myeloma : Subanalysis of OPTIMISMM
    17th International Myeloma Workshop ; September 12-15, 2019, Boston, MA, USA,
    In: Clinical Lymphoma, Myeloma & Leukemia , Jg. 19 2019, Nr. 10, Suppl., S. e32 – e33
    DOI
  • Dimopoulos, Meletios A.; Weisel, Katja C.; Moreau, Philippe; Anderson, Larry D.; White, Darrell J; San-Miguel, Jesús; Sonneveld, Pieter; Engelhardt, Monika; Jenner, Matthew; Corso, Alessandro; Dürig, Jan; Pavic, Michel; Salomo, Morten; Casal, Eva; Jiang, Ruiyun; Srinivasan, Shankar; Nguyen, Tuong Vi; Biyukov, Tsvetan; Peluso, Teresa; Richardson, Paul G.
    Pomalidomide + Bortezomib + Low-Dose Dexamethasone after 1 Prior Line of Therapy in Patients with Lenalidomide-Pretreated Multiple Myeloma : Subanalysis of the Phase 3 Optimismm Trial By Patient Age and Prior Stem Cell Transplant
    61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Oralndo, USA,
    In: Blood , Jg. 134 2019, Nr. Supplement_1, S. 3120 – 3120
    DOI (Open Access)
  • Grząśko, Norbert; Knop, Stefan; Goldschmidt, Hartmut; Raab, Marc S; Dürig, Jan; Bringhen, Sara; D'Agostino, Mattia; Gamberi, Barbara; Rivolti, Elena; Vacca, Angelo; Ria, Roberto; Jurczyszyn, Artur; Castellano Acosta, Jorge; Lang, Doris; Lemaillet, Guy; Sudhir, Bansod; Szarejko, Monika
    The MP0250-CP201 Mirror Study : A Phase 2 Study Update of MP0250 Plus Bortezomib and Dexamethasone in Relapse/Refractory Multiple Myeloma (RRMM) Patients Previously Exposed to Proteasome Inhibitors and Immunomodulatory Drugs
    61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Oralndo, USA,
    In: Blood , Jg. 134 2019, Nr. Supplement_1: Annual Meeting Abstracts, S. 1899 – 1899
    DOI (Open Access)
  • Rummel, Mathias J; Lerchenmüller, Christian; Hensel, Manfred; Goerner, Martin; Buske, Christian; Schulz, Holger; Schmidt, Burkhard; Kojouharoff, Georgi; Lange, Elisabeth; Willenbacher, Wolfgang; Dürig, Jan; Engel, Erik; Kauff, Frank; Barth, Jürgen; Burchardt, Alexander Christoph; Hinke, Axel; Wupperfeld, Jasmin; Greil, Richard
    Two Years Rituximab Maintenance Vs. Observation after First Line Treatment with Bendamustine Plus Rituximab (B-R) in Patients with Waldenström's Macroglobulinemia (MW) : Results of a Prospective, Randomized, Multicenter Phase 3 Study (the StiL NHL7-2008 MAINTAIN trial)
    61st ASH Annual Meeting and Exposition, 07.-10.12.2019, Orlando, FL,
    In: Blood , Jg. 134 2019, Nr. Supplement_1, S. 343
    DOI (Open Access)
  • Egle, A.; Jäger, U.; Skrabs, C.; Dürig, Jan; Nösslinger, T.; Wanner, D.; Steurer, M.; Ringshausen, I.; Melchardt, T.; Greil, R.; Ysebaert, L.
    Unmaintained remission after discontinuation of kinase inhibitor treatment in chronic lymphocytic leukemia: an observational cohort
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment , Jg. 42 2019, Nr. Supplement 4: Abstracts, S. 18
    DOI (Open Access)
  • Schmidt, Christian; Zoellner, Anna-Katharina; Jurinovic, Vindi; Sökler, Martin; Forstpointner, Roswitha; Haubner, Sascha; Buske, Christian; Viardot, Andreas; Keller, Ulrich; Pott, Christiane; Graeven, Ullrich; Marks, Reinhard; Hänel, Mathias; Liersch, Ruediger; Dürig, Jan; Hoster, Eva; Unterhalt, Michael; Hiddemann, Wolfgang
    Chemotherapy-Free Combination of Obinutuzumab and Ibrutinib in First LINE Treatment of Follicular Lymphoma : The Alternative Study By the German Low Grade Lymphoma Study Group (GLSG)
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood , Jg. 132 2018, Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 448 – 448
    DOI (Open Access)
  • Rummel, M.; Buske, C.; Hertenstein, B.; Lerchenmüller, C. A.; Koenigsmann, M.; Lange, E.; Reeb, M.; Kaiser, U.; Balser, C.; Behringer, D.; Dürig, Jan; Gaska, T.; Maschmeyer, G.; Schliesser, G.; Burchardt, A.; Barth, J.; Kauff, F.; Hinke, A.; Greil, R.
    Four versus two years of Rituximab maintenance (R-maintenance) following Bendamustine plus Rituximab (B-R): initial results of a prospective, randomized multicenter phase 3 study in first-line follicular lymphoma (the StiL NHL7-2008 MAINTAIN study)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 4, S. 251
    DOI (Open Access)
  • Keuneke, L.; Ossowski, J.; Becher, C.; Dürig, Jan; Johansson, Patricia; Bergmann, A. K.; Murga Penas, E. M.
    Gain of STAT3/5 locus is a recurrent cryptic aberration in T-cell prolymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 4, S. 318
    DOI (Open Access)
  • Knop, Stefan; Goldschmidt, Hartmut; Raab, Marc S; Szarejko, Monika; Jurczyszyn, Artur; Dürig, Jan; Bringhen, Sara; Gamberi, Barbara; Vacca, Angelo; Castellano Acosta, Jorge; Lemaillet, Guy; Cortijo, Cedric; Sudhir, Bansod; Grząśko, Norbert
    MP0250 Combined with Bortezomib and Dexamethasone in Multiple Myeloma Patients Previoulsy Exposed to Proteasome Inhibitors and Immunomodulatory Drugs
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood , Jg. 132 2018, Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 1980 – 1980
    DOI (Open Access)
  • Dimopoulos, Meletios A; Weisel, Katja; Moreau, Philippe; Anderson, Larry; White, Darrell J; San-Miguel, Jesus F; Sonneveld, Pieter; Engelhardt, Monika; Jenner, Matthew W; Corso, Alessandro; Dürig, Jan; Pavic, Michel; Salomo, Morten; Yu, Xin; Nguyen, Tuong Vi; Bensmaine, Amine; Peluso, Teresa; Zaki, Mohamed; Richardson, Paul
    Pomalidomide + Bortezomib + Low-Dose Dexamethasone Vs Bortezomib + Low-Dose Dexamethasone As Second-Line Treatment in Patients with Lenalidomide-Pretreated Multiple Myeloma : A Subgroup Analysis of the Phase 3 Optimismm Trial
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood , Jg. 132 2018, Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 3278 – 3278
    DOI (Open Access)
  • Weisel, K.; Salwender, H.; Scheid, C.; Zago, M.; Besemer, B.; Hänel, M.; Dürig, Jan; Munder, M.; Lindemann, H.-W.; Seckinger, A.; Kunz, C.; Benner, A.; Hose, D.; Jauch, A.; Kanz, L.; Goldschmidt, H.; GMMG
    Pomalidomide, cyclophosphamide and dexamethasone in case of suboptimal response to pomalidomide and dexamethasone alone in relapsed and/or refractory multiple myeloma : Final results of the GMMG-PERSPECTIVE trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 4, S. 133 – 134
    DOI (Open Access)
  • Dürig, Jan
    Preliminary data of the ongoing open-label, single-arm phase II study of MP0250 in combination with bortezomib plus dexamethasone in patients with relapsed refractory multiple myeloma
    In: Haematologica / The Hematology Journal , Jg. 103 2018, Nr. Suppl. 1
  • Ossowski, J.; Keuneke, L.; Richter, J.; Dührsen, U.; Küppers, Ralf; Dürig, Jan; Johansson, Patricia; Murga Penas, E. M.; Bergmann, A. K.
    The DNA-methylation status of BCL11B in T-Cell-Large Granular Lymphocytic Leukemia - a diagnostic target
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 4, S. 317
    DOI (Open Access)
  • Seckinger, Anja; Salwender, Hans Jürgen; Martin, Hans; Scheid, Christof; Hielscher, Thomas; Bertsch, Uta; Hummel, Manuela; Jauch, Anna; Knauf, Wolfgang; Emde, Martina; Beck, Susanne; Neben, Kai; Lokhorst, Henk M.; van der Holt, Bronno; Duehrsen, Ulrich; Dürig, Jan; Lindemann, Hans-Walter; Schmidt-Wolf, Ingo; Haenel, Mathias; Lathan, Bernd; Raab, Marc S; Müller-Tidow, Carsten; Sonneveld, Pieter; Blau, Igor Wolfgang; Hillengass, Jens; Weisel, Katja; Goldschmidt, Hartmut; Hose, Dirk
    Treatment Response and Long-Term Survival in Multiple Myeloma in the GMMG-HD4 Trial - Neither Profit All Molecular Entities Alike, Nor Are Remissions to Different Regimen Equal
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood , Jg. 132 2018, Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 4485 – 4485
    DOI (Open Access)
  • Johansson, Patricia; Habenberger, Peter; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Küppers, Ralf; Schultz-Fademrecht, Carsten; Choidas, Axel; Dürig, Jan
    CDK9 Inhibition with LDC526 Is an Effective Treatment for T-Cell Prolymphocytic Leukemia (T-PLL) in Vitro
    In: Blood , Jg. 130 2017, Nr. Suppl. 1, S. 1262
    DOI
  • Johansson, Patricia; Pancaldi, V.; Castellano, G.; Oschlies, I.; Queiros, A.; Iaccarino, I.; Valencia, A.; Martin-Subero, J. I.; Penas, EMM; Ammerpohl, O.; Dührsen, Ulrich; Küppers, Ralf; Dürig, Jan; Siebert, R.; Pau, ECD; Bergmann, A. K.
    Epigenetic analyses of T-cell large granular lymphocytic leukemia identify differentially methylated enhancer regions leading to deregulation of gene interactions
    In: Oncology Research and Treatment , Jg. 40 2017, Nr. Suppl. 3, Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 109 – 110
    DOI
  • Dührsen, Ulrich; Hüttmann, Andreas; Muller, S.; Hertenstein, B.; Thomssen, H.; Kotzerke, J.; Mesters, R.; Berdel, W. E.; Franzius, C.; Kroschinsky, F.; Weckesser, M.; Kofahl-Krause, D.; Bengel, F. M.; Dürig, Jan; Matschke, Johannes; Pöppel, Thorsten; Ose, C.; Brinkmann, M.; La Rosee, P.; Freesmeyer, M.; Hertel, A.; Hoffkes, H. G.; Behringer, D.; Prange-Krex, G.; Wilop, S.; Krohn, T.; Holzinger, J.; Griesshammer, M.; Giagounidis, A.; Raghavachar, A.; Maschmeyer, G.; Brink, I.; Bernhard, H.; Haberkorn, U.; Gaska, T.; Kurch, L.; Klapper, W.; Hoelzer, D.; Geworski, L.; Jöckel, Karl-Heinz; Scherag, Andre; Rekowski, J.; Bockisch, Andreas; PETAL Trial Investigators
    Positron-emission tomography-guided therapy of aggressive non-Hodgkin lymphomas -final results of the PETAL trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 29. September-3. Oktober 2017, Stuttgart, Germany,
    In: Oncology Research and Treatment , Jg. 40 2017, Nr. Suppl. 3, S. 202 – 203
    DOI
  • Johansson, Patricia; Klein-Hitpaß, Ludger; Bergmann, A.; Siebert, R.; Scholtysik, R.; Przekopowitz, M.; Seifert, M.; Zenz, T.; Dührsen, Ulrich; Küppers, Ralf; Dürig, Jan
    Genomic profiling of T-cell Prolymphocytic Leukemia (T-PLL) identifies novel recurrent mutations in SAMHD1 and PTPRC
    Jahrestagung der ­Deutschen, Österreichischen und ­Schweizerischen ­Gesellschaften für Hämatologie und ­Medizinische Onkologie, Leipzig, 14.–18. Oktober 2016,
    In: Oncology Research and Treatment , Jg. 39 2016, Nr. Suppl. 3, S. 238 – 238
    DOI
  • Rost, S.; Mollmann, M.; Eisele, Lewin; Weber, S.; Opalka, Bertram; Dührsen, Ulrich; Dürig, Jan; Göthert, Joachim Rudolf
    Establishment of a real-time PCR assay to quantify the size of a NOTCH1 mutated subclone in chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 60
    DOI
  • Zesewitz, M. L.; Eisele, Lewin; Weber, S.; Mollmann, M.; Rost, S.; Dührsen, Ulrich; Dürig, Jan; Göthert, Joachim Rudolf
    Expansion of a stimulatory natural killer receptor NKp80-expessing CD8+T-cell subset in chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 191
    DOI
  • Johansson, Patricia; Nückel, Holger; Dührsen, Ulrich; Dürig, Jan
    Percentage of smudge cells on routine blood smears predict time to first treatment and overall survival in patients with Binet stage A chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,
    In: Onkologie , Jg. 34 2011, Nr. Suppl. 6, S. 139
    DOI
  • Imsak, R.; Göthert, Joachim Rudolf; Möllmann, M.; Dührsen, Ulrich; Eickhoff, J.; Baumann, M.; Unger, A.; Schulz-Fademrecht, C.; Dürig, Jan
    Preclinical testing of a novel CDK9 inhibitor in chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,
    In: Onkologie , Jg. 34 2011, Nr. Suppl. 6, S. 195 – 196
    DOI
  • Göbel, M.; Eisele, Lewin; Huttmann, A.; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan
    Progranulin plasma levels predict time to first treatment and overall survival in chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,
    In: Onkologie , Jg. 34 2011, Nr. Suppl. 6, S. 196 – 196
    DOI
  • Carpinteiro, Alexander; Keitsch, S.; Hessler, G.; Pozgajova, M.; Müller, Stefan; Dürig, Jan; Gulbins, Erich
    Role of the acid sphingomyelinase in hematogenous tumor metastasis in a mouse model
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,
    In: Onkologie , Jg. 34 2011, Nr. Suppl. 6, S. 46
    DOI
  • Kapp, Johanna; Ochsenfarth, Crista; Switala, Magdalena; Frey, Ulrich; Sellmann, Ludger; Dürig, Jan; Horn, Peter; Dührsen, Ulrich; Rebmann, Vera; Nuckel, Holger
    Association of HLA-G Haplotype Risk Model with Treatment Free Survival In Chronic Lymphocytic Leukemia Patients
    In: Blood , Jg. 116 2010, Nr. 21, S. 1002 – 1003
    DOI
  • Kapp, Johanna; Ochsenfarth, Crista; Switala, Magdalena; Frey, Ulrich; Sellmann, Ludger; Dürig, Jan; Horn, Peter; Dührsen, Ulrich; Rebmann, Vera; Nückel, Holger
    Association of HLA-G haplotype risk model with treatment free survival in chronic lymphocytic leukemia patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, Berlin, Oktober 2010,
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6, S. 45
    DOI
  • Gigel, C.; Eisele, Lewin; Mollmann, M.; Klein-Hitpaß, Ludger; Koch, T.; Hansen, JBR; Orum, H.; Wissenbach, M.; Dührsen, Ulrich; Dürig, Jan
    Comparing the pharmacological effects of the novel Locked Nucleic Acid (LNA) modified antisense Bcl-2 inhibitor SPC2996 and G3139 (oblimersen) in preclinical models of chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6, S. 184
    DOI
  • Gothert, J. R.; Eisele, Lewin; Klein-Hitpaß, Ludger; Weber, Stefanie; Fuhrer, A.; Sellmann, Ludger; Roth, A.; Pircher, H.; Duhrsen, U.; Dürig, Jan
    Expanded CD8(+) T-cells of murine and human B-CLL are driven into a senescent KLRG1(+) effector memory phenotype
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6, S. 201
    DOI
  • Gothert, Joachim Rudolf; Eisele, Lewin; Klein-Hitpaß, Ludger; Weber, Stefanie; Fuhrer, Anja; Sellmann, Ludger; Röth, Alexander; Dührsen, Ulrich; Pircher, Hanspeter; Dürig, Jan
    Expanded CLL CD8(+) T-Cells Are Driven Into a Senescent KLRG1(+) Effector Memory Phenotype
    In: Blood , Jg. 116 2010, Nr. 21, S. 403
  • Buttkereit, Ulrike; Mohamad, Sana; Lindemann, Monika; Göthert, Joachim Rudolf; Opalka, Bertram; Dürig, Jan; Dührsen, Ulrich
    Heterogeneous Interactions of Leukemic and Control Bone Marrow Stroma Cells with an AML Cell Line and AML Leukemic Blasts
    In: Blood , Jg. 116 2010, Nr. 21, S. 460
    DOI
  • Buttkereit, U.; Mohamad, Sana; Lindemann, Monika; Göthert, Joachim Rudolf; Opalka, Bertram; Dürig, Jan; Dührsen, Ulrich
    Heterogeneous interactions of leukemic and control bone marrow stroma cells with an AML cell line and AML leukemic blasts
    Deutsche, Österreichische und Schweizerische Gesellschaften für Hämatologie und Onkologie Jahrestagung, Berlin, Oktober 2010,
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6, S. 235
    DOI
  • Nückel, Holger; Switala, Magdalena; Ochsenfarth, Crista; Dürig, Jan; Horn, Peter; Dührsen, Ulrich; Rebmann, Vera
    High soluble MICA levels are associated to MICA-129 val/val genotypes and poor treatment free survival in chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6, S. 41 – 42
    DOI
  • Möllmann, M.; Eisele, Lewin; Göthert, Joachim Rudolf; Grabellus, Florian; Weber, S.; Dührsen, Ulrich; Dürig, Jan
    Investigating the interaction of leukemic B and non-malignant T cells in a novel Rag2-/gamma c-/--xenograft model of human chronic lymphocytic leukemia (CLL)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6, S. 202
    DOI
  • Eisele, Lewin; Günther, F.; Ebeling, Peter; Nabring, J.; Dührsen, Ulrich; Dürig, Jan
    Outpatient management of acute myeloid leukemia after intensive consolidation chemotherapy is feasible and reduces hospital treatment costs
    In: Oncology , Jg. 33 2010, Nr. 12, S. 658 – 664
    DOI
  • Johansson, Patricia; Hollenbeck, Anita; Horn, Peter; Dührsen, Ulrich; Gerken, Guido; Dürig, Jan; Schlaak, Jörg Friedrich
    Polyclonal B-Cell activation and Expansion of Monoclonal B Cells in the Peripheral Blood of Patients with Chronic Hepatitis C
    In: Hepatology , Jg. 52 2010, Nr. Suppl. 1, S. 740A
    DOI
  • Johansson, Patricia; Hollenbeck, Anita; Klein-Hitpaß, Ludger; de Dechene, Maldonado E; Eisele, Lewin; Kieruzel, Sabrina; Horn, Peter; Schmücker, Ute; Vetter, Ina; Gerken, Guido; Dührsen, Ulrich; Dürig, Jan; Schlaak, Jörg Friedrich
    Prevalence of B cell lymphoproliferative disorders in patients with chronic hepatitis C (CHC)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010, pp 109–206,
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6, S. 157
    DOI
  • Eisele, Lewin; Dürig, Jan; Hüttmann, Andreas; Dührsen, Ulrich; Führer, Anja; Kieruzel, Sabrina; Assert, Roland; Bokhof, Beate; Erbel, Raimund; Mann, Klaus; Jöckel, Karl-Heinz; Moebus, Susanne
    Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Light-Chain MGUS (LCMGUS) In a Metropolitan Area In Germany
    In: Blood , Jg. 116 2010, Nr. 21, 4037
    DOI
  • Carpinteiro, Alexander; Keitsch, S.; Möllmann, M.; Dührsen, Ulrich; Dürig, Jan; Gulbins, Erich
    Role of the antigenic stimulation in the pathogenesis of chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6, S. 39
    DOI
  • Dürig, Jan; Klein-Hitpaß, Ludger; Worm, J.; Hansen, JBR; Orum, H.; Dührsen, U.; Wissenbach, M.
    The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6, S. 42
    DOI

    • Beiträge in Sammelwerken und Tagungsbänden

  • Dürig, Jan
    Large Granular Lymphocyte Leukemia
    In: Chronic Lymphocytic Leukemia / Hallek, Michael; Eichhorst, Barbara; Catovsky, Daniel (Hrsg.) 2019, S. 167 – 179
    DOI (Open Access)

    • Poster / Posterbeiträge

  • Mai, Elias; Hielscher, Thomas; Bertsch, Uta; Salwender, Hans J.; Munder, Markus; Brossart, Peter; Blau, Igor W.; Raab, Marc; Dürig, Jan; Giesen, Nicola; Besemer, Britta; Fenk, Roland; Wattad, Mohammed; Haenel, Mathias; von Metzler, Ivana; Graeven, Ullrich; Scheid, Christoph; Weisel, Katja; Goldschmidt, Hartmut
    Predictive factors for severe infections and early death during novel agent-based induction therapy in newly diagnosed, transplant-eligible myeloma : a multicohort analysis from phase III trials
    18th International Myeloma Workshop ; September 8 - 11, 2021, Vienna, Austria,
    In: Clinical Lymphoma, Myeloma & Leukemia , Jg. 21 2021, Nr. Suppl. 2, S. S133 – S134
    DOI
  • Johansson, Patricia; Dierichs, L.; Klein-Hitpaß, Ludger; Bergmann, A.; Menninger, S.; Habenberger, P.; Klebl, B.; Siveke, Jens; Dührsen, U.; Choidas, A.; Dürig, Jan
    Anti-leukemic activity through CDK9 inhibition in T-cell prolymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment , Jg. 42 2019, Nr. Supplement 4: Abstracts, S. 218
    DOI (Open Access)